b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2832691/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832691/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry" /><meta name="citation_authors" content="Iain J. MacLeod, Tony Minson" /><meta name="citation_date" content="2010" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="5" /><meta name="citation_doi" content="10.1371/journal.pone.0009560" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2832691/?report=abstract" /><meta name="citation_pmid" content="20221426" /><meta name="DC.Title" content="Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Iain J. MacLeod" /><meta name="DC.Contributor" content="Tony Minson" /><meta name="DC.Date" content="2010" /><meta name="DC.Identifier" content="10.1371/journal.pone.0009560" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry" /><meta property="og:type" content="article" /><meta property="og:description" content="The envelope of HSV-1 contains a number of glycoproteins, four of which are essential for virus entry. Virus particles lacking gB, gD, gH or gL are entry-defective, although these viruses retain the ability to bind to the plasma membrane via the remaining ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832691/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2832691/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2832691/pdf/pone.0009560.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B6431E9A371110000000007BF07BD.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/185351/">v.5(3); 2010</a></li><li class="accid">PMC2832691</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0009560" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2010; 5(3): e9560. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Mar 5. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0009560" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0009560</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2832691</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20221426">20221426</a></div></div></div></div><h1 class="content-title">Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=MacLeod%20IJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20221426" class="affpopup" co-rid="_co_idm140037134184528" co-class="co-affbox">Iain J. MacLeod</a><sup></sup><sup>\n&#x0002a;\n,</sup><sup>\n&#x000a4;\n</sup> and  <a href="/pubmed/?term=Minson%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20221426" class="affpopup" co-rid="_co_idm140037171918960" co-class="co-affbox">Tony Minson</a><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140037134184528"><h3 class="no_margin">Iain J. MacLeod</h3><p>  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=MacLeod%20IJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20221426">Iain J. MacLeod</a></div></div><div id="_co_idm140037171918960"><h3 class="no_margin">Tony Minson</h3><p>  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Minson%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20221426">Tony Minson</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Ding Xiang Liu, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140037133923952_ai idm140037134184656_ai idm140037123262496_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140037133923952_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140037133923952_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140037133923952_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom,   </div><div class="fm-affl" lang="en" id="edit1">Institute of Molecular and Cell Biology, Singapore</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="ude.dravrah.hpsh@doelcami" class="oemail">ude.dravrah.hpsh@doelcami</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: IJM TM. Performed the experiments: IJM. Analyzed the data: IJM. Contributed reagents/materials/analysis tools: IJM. Wrote the paper: IJM TM.</p></div><div id="fn1"><sup>&#x000a4;</sup>Current address: Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140037133923952_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Oct 1; Accepted 2010 Feb 16.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140037133923952_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> MacLeod, Minson.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2832691/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="3" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Table S1: </strong>Normalised datasets for genes differentially expressed on a signalling-specific microarray after infection with entry-defective HSV-1.<p>(0.14 MB XLS)</p></div><div><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s001.xls" data-ga-action="click_feat_suppl">pone.0009560.s001.xls</a><span style="color:gray"> (133K)</span></div><div class="small guid">GUID:\xc2\xa0EDD77324-E12E-406F-96AC-C26F66BFDFAE</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Table S2: </strong>Primers used in real-time PCR to determine the relative abundance of corresponding mRNA transcripts.<p>(0.28 MB DOC)</p></div><div><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s002.doc" data-ga-action="click_feat_suppl">pone.0009560.s002.doc</a><span style="color:gray"> (274K)</span></div><div class="small guid">GUID:\xc2\xa0F8DE5756-D98B-4080-B119-A3421F516EF3</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Figure S1: </strong>Characteristics of virions treated with PNGase.<p>(0.76 MB PDF)</p></div><div><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s003.pdf" data-ga-action="click_feat_suppl">pone.0009560.s003.pdf</a><span style="color:gray"> (738K)</span></div><div class="small guid">GUID:\xc2\xa0AB3CB329-C745-4CAB-9A1C-E5D9082719AB</div></div></dd></dl></div><div id="idm140037172935840" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140037172935840title">Abstract</h2><!--article-meta--><div><p id="__p3" class="p p-first-last">The envelope of HSV-1 contains a number of glycoproteins, four of which are essential for virus entry. Virus particles lacking gB, gD, gH or gL are entry-defective, although these viruses retain the ability to bind to the plasma membrane via the remaining glycoproteins. Soluble forms of gD have been shown to trigger the nuclear translocation of the NF-&#x003ba;B transcriptional complex in addition to stimulating the production of Type I interferon. By taking advantage of the entry-defective phenotype of glycoprotein-deficient HSV-1 virus particles, the results presented here show that binding of virions to cellular receptors on the plasma membrane is sufficient to stimulate a change in cellular gene expression. Preliminary microarray studies, validated by quantitative real-time PCR, identified the differential expression of cellular genes associated with the NF-&#x003ba;B, PI3K/Akt, Jak/Stat and related Jak/Src pathways by virions lacking gB or gH but not gD. Gene induction occurred at a few particles per cell, corresponding to physiological conditions during primary infection. Reporter assay studies determined that NF-&#x003ba;B transcriptional activity is stimulated within an hour of HSV-1 binding, peaks between two and three hours post-binding and declines to background levels by five hours after induction. The immediate, transient nature of these signalling events suggests that HSV-1 glycoproteins, particularly gD, may alter the cellular environment pre-entry so as to condition the cell for viral replication.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p4" class="p p-first">Subjugation of the intracellular environment by viruses is essential to ensure the effective expression and replication of the viral genome to allow production of progeny virions. One such viral strategy involves hijacking signalling pathways that ultimately control host gene transcription. Interactions between intracellular viral proteins and cellular kinases responsible for signal transduction are a means by which to achieve this. However, there is growing evidence to support the premise that glycoproteins on the surface of virus particles may trigger intracellular signalling pathways by interacting with their cognate receptors on the host cell membrane <a href="#pone.0009560-Sciortino1" rid="pone.0009560-Sciortino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235189">[1]</a>.</p><p id="__p5">Binding of HSV-1 to permissive cells occurs through viral glycoproteins on the viral envelope interacting with specific receptors on the cell surface, triggering fusion of the plasma membrane with the outer envelope. Five of these glycoproteins are known to be involved in virion binding to the cell surface: gB, gC, gD and the heterodimer gH-L. Of the five, only gC is dispensable for allowing productive infection as deletion of gB, gD or gH-L results in an entry-defective phenotype <a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235170">[2]</a>\n<a href="#pone.0009560-Browne1" rid="pone.0009560-Browne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235173">[3]</a>. gD is known to bind independently to HvEM, nectin-1 and nectin-2, whereas gH interacts with the &#x003b1;v&#x003b2;3 integrin, with the paired immunoglobulin-like receptor, PILR&#x003b1;, acting as a receptor for gB <a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235178">[2]</a>\n<a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235203">[4]</a>\n<a href="#pone.0009560-Browne1" rid="pone.0009560-Browne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235175">[5]</a>.</p><p id="__p6">One of the first studies to examine whether HSV-1 glycoproteins play a role in the induction of signalling found that gD was able to block Fas-mediated apoptosis <a href="#pone.0009560-Medici1" rid="pone.0009560-Medici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235182">[6]</a>. U937 monocytoid cells were rendered resistant to apoptosis after infection with UV-inactivated HSV virions, when co-cultured with a stably transfected HSV-1 gD-expressing cell line or after treatment with soluble gD. Inhibition of NF-KB signalling by the introduction of a dominant-negative NF-&#x003ba;B repressor abolished protection from gD-induced Fas-mediated apoptosis. More specifically, the interaction of gD with one of the gD receptors, HVEM, was involved in preventing apoptosis induction <a href="#pone.0009560-Sciortino1" rid="pone.0009560-Sciortino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235181">[1]</a>.</p><p id="__p7">There are reports showing that HSV-1 triggered the translocation of NF-&#x003ba;B by six hours post-infection <a href="#pone.0009560-Patel1" rid="pone.0009560-Patel1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235174">[7]</a>. However, it has come to light that HSV-1 may induce two distinct phases of NF-&#x003ba;B activity. The initial phase is transient, lasting only two hours, and occurred shortly after viral adsorption by both wild-type and UV-inactivated virus particles. This correlates with evidence showing that supernatant taken from gD-expressing cells may also cause an increase in NF-KB binding activity in monocytoid cells by 30 minutes post-treatment <a href="#pone.0009560-Medici1" rid="pone.0009560-Medici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235167">[6]</a>. A second phase relied on <em>de novo</em> viral protein synthesis as it was stimulated only by replication-competent HSV-1 and not by UV-inactivated virions <a href="#pone.0009560-Amici1" rid="pone.0009560-Amici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235192">[8]</a>. During this second phase, NF-&#x003ba;B complexes were shown to have associated with their consensus sequence found in the promoter region that drives ICP0 expression <a href="#pone.0009560-Amici1" rid="pone.0009560-Amici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235165">[8]</a>.</p><p id="__p8">In comparison to wild-type gD, a mutated form of gD that was unable to bind to HVEM did not stimulate NF-KB activity in co-cultured monocytoid cells <a href="#pone.0009560-Sciortino2" rid="pone.0009560-Sciortino2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235215">[9]</a>. HEp-2 cells, which do not express HVEM, lacked detectable NF-&#x003ba;B signalling after infection with UV-inactivated HSV-1, implying that gD-mediated NF-&#x003ba;B stimulation may be dependent on expression of HVEM <a href="#pone.0009560-Sciortino2" rid="pone.0009560-Sciortino2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235212">[9]</a>.</p><p id="__p9">Soluble glycoproteins from beta- and gammaherpesviruses can also stimulate intracellular signalling pathways; gB of CMV has been shown to stimulate the differential expression of cellular transcription factors and interferon-stimulated genes (ISGs), and soluble gp350 of EBV can trigger NF-&#x003ba;B activation <a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235169">[10]</a>\n<a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235177">[11]</a>\n<a href="#pone.0009560-Browne1" rid="pone.0009560-Browne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235158">[12]</a>.</p><p id="__p10">The treatment of cells with soluble glycoproteins or UV-inactivated virus has provided strong evidence that HSV-1 binding to the plasma membrane triggers signal transduction in the host cell as a prelude to infection, but interpretation of these experiments is not straightforward. The use of soluble glycoproteins does not mimic the binding of individual virus particles and the physiological significance of the results is difficult to assess. The use of UV-inactivated particles in signalling studies simulates infection but these particles are able to enter cells and deliver virion proteins to the cytoplasm. Experiments with UV-inactivated particles do not therefore distinguish between events arising from virus binding from those resulting from virus entry.</p><p id="__p11" class="p p-last">The main focus in these studies was to examine signalling events using virus particles that are capable of binding to the cell surface but are incapable of entry due to the absence of one of the three essential glycoproteins, gB, gD or gH <a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235214">[13]</a>\n<a href="#pone.0009560-Heldwein1" rid="pone.0009560-Heldwein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235206">[14]</a>\n<a href="#pone.0009560-Browne1" rid="pone.0009560-Browne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235209">[15]</a>\n<a href="#pone.0009560-Browne1" rid="pone.0009560-Browne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235164">[16]</a>, and to find whether signalling occurs at particle concentrations that would mirror physiological conditions.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Viruses and Cells</h3><p id="__p12" class="p p-first">All cells other than Human Foreskin Fibroblasts (HFF) (ATCC cell line CRL-2522) were grown in Glasgow Modified Eagles Medium supplemented with 10&#x00025; foetal bovine serum, 4 mM glutamine, 100 units/ml penicillin and 100 ug/ml streptomycin. HFF cells were grown in Dulbecco modified Eagles medium supplemented as described above but with the addition of 1x MEM non-essential amino acids.</p><p id="__p13">Working stocks of HSV-1 SC16 were grown on HaCaT cells and assayed on Vero cells <a href="#pone.0009560-NaldinhoSouto1" rid="pone.0009560-NaldinhoSouto1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235202">[17]</a>. Mutant viruses lacking functional genes for gH (SCgHZ) <a href="#pone.0009560-Forrester1" rid="pone.0009560-Forrester1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235190">[14]</a>, gB (HFEMdUL27-lacZ) <a href="#pone.0009560-Babic1" rid="pone.0009560-Babic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235218">[18]</a> or gD (SC16gDdelZ) <a href="#pone.0009560-Babic1" rid="pone.0009560-Babic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235184">[18]</a> were grown and assayed on helper cell lines expressing the corresponding glycoprotein: CR1 cells, expressing gH <a href="#pone.0009560-Boursnell1" rid="pone.0009560-Boursnell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235213">[19]</a>; D6 cells expressing gB <a href="#pone.0009560-Cai1" rid="pone.0009560-Cai1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235187">[13]</a>; and VD60 cells expressing gD <a href="#pone.0009560-Babic1" rid="pone.0009560-Babic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235217">[18]</a>. All stocks were grown using an MOI of 0.1.</p><p id="__p14" class="p p-last">Purified preparations of WT virus, or of virions lacking individual glycoproteins, were produced as previously described <a href="#pone.0009560-Rodger1" rid="pone.0009560-Rodger1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235195">[20]</a>. Purified preparations were assayed for particle numbers using electron microscopy <a href="#pone.0009560-Watson1" rid="pone.0009560-Watson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235185">[21]</a> and for infectivity by plaque assay on Vero cells or, in the case of glycoprotein-deficient virions, on the relevant helper cell line. Preparations of WT virions had a particle to infectivity ratio of 3&#x000d7;10<sup>1</sup>. Preparations of gH-negative, gD-negative and gB negative virions had particle to infectivity ratios of 2&#x000d7;10<sup>10</sup>, 5&#x000d7;10<sup>6</sup> and 3&#x000d7;10<sup>6</sup> respectively. The maximum virion dose of entry-incompetent virions used in the experiments described in this paper was 1000 particles per cell and it therefore follows that in the maximum infectivity of a preparation of an entry-defective virus (i.e. using gB-negative virions) would be less than one cell per thousand. Virus preparations were deglycosylated with 500 U of PNGase F for 18 hrs at 37&#x000b0;C in the absence of denaturing buffer <a href="#pone.0009560-Paludan1" rid="pone.0009560-Paludan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235208">[22]</a>. Removal of N-linked sugars was confirmed by a shift in the electrophoretic mobility of gD on a protein denaturing gel.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Signalling Experiments</h3><p id="__p15" class="p p-first-last">Human foreskin fibroblast cells (HFF) were seeded at 1.5&#x000d7;10<sup>6</sup> in a 175<sup>2</sup> cm flask and grown to 90&#x00025; confluence then growth-arrested in medium supplemented with only 100 U/ml Penicillin-G and 100 &#x000b5;g/ml Streptomycin for five days. Real-time PCR experiments were conducted with growth-arrested HFFs that were inoculated in triplicate with 1000 particles/cell of entry-defective HSV-1 in warm, serum-free medium, with parallel mock-infected cells that received an equivalent volume of PBS in warm serum-free medium. Inoculations took place at 37&#x000b0;C. At the indicated times after the addition of virus, the medium was removed, the cells were lysed with TRI Reagent (Sigma) and total RNA was immediately purified. For each entry-defective HSV-1 mutant, three independent biological replicates were carried out. Microarray experiments were conducted under the same conditions using wild-type HSV-1 (SC16) at an MOI of 20.</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">RNA Purification and cDNA Preparation</h3><p id="__p16" class="p p-first-last">Total RNA was isolated from TRI reagent lysates as per the manufacturer\'s instructions. Contaminating genomic DNA was digested with 2 U DNase I (Invitrogen) and RNA was re-purified with TRI reagent. cDNA was derived from 30 &#x000b5;g total RNA using anchored oligo (dT)20 primers (Invitrogen) as described in the manufacturer\'s instructions. For each entry-defective HSV-1 mutant, the cDNA from three independent infections were used in technical triplicates for real-time PCR reactions.</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Signalling-Specific Microarray</h3><p id="__p17" class="p p-first-last">Microarray analysis was carried out using the Signal Transduction PathwayFinder cDNA array as per the manufacturer\'s instructions (Superarray). Nylon cDNA microarrays membranes were pre-hybridised with supplied sheared salmon sperm DNA at 60&#x000b0;C for one to two hours. The pre-hybridisation solution was replaced with the biotin-dUTP labelled cDNA probe, which was diluted in sheared salmon sperm DNA. The solution was left to hybridise at 60&#x000b0;C overnight. The following morning the cDNA probe was discarded and the membrane was washed twice then blocked in Solution Q, as provided by the manufacturer. After 40 minutes, the blocking solution was discarded and the membrane was incubated with a binding buffer, Solution F. After washing, the chemiluminescent substrate was incubated with the membrane for two to five minutes at room temperature. The microarray membrane was then exposed to X-ray film. Analysis was performed using GEArray Expression Analysis Suite as provided by the manufacturer (Superarray). All the data sets used in the microarray analysis are available in <a href="#pone.0009560.s001" rid="pone.0009560.s001" class=" supplementary-material">Table S1</a>.</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Real-Time PCR</h3><p id="__p18" class="p p-first">cDNA derived from cells that were mock-infected or inoculated with 1000 particles/cell of entry-defective &#x00394;gB, &#x00394;gD and &#x00394;gH virions was used for real-time PCR analysis. Primers were designed, using the Primer3 software <a href="#pone.0009560-Rozen1" rid="pone.0009560-Rozen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235183">[23]</a>, to anneal at 60&#x000b0;C, with a minimum product melting temperature of 80&#x000b0;C (<a href="#pone.0009560.s002" rid="pone.0009560.s002" class=" supplementary-material">Table S2</a>). Reactions were set-up with cDNA corresponding to 100 ng total RNA, primers (70 nM), and 10 &#x000b5;l SYBR Green PCR master mix (Abgene) made to a total volume of 20 &#x000b5;l with nuclease-free dH<sub>2</sub>O. A Corbett Rotorgene 3000 was used to determine the levels of SYBR green fluorescence over 40 cycles. Samples were denatured for 10 minutes at 95&#x000b0;C, annealed at 60&#x000b0;C for 30 seconds, with extension of the primer product at 72&#x000b0;C for 40 seconds then a final 80&#x000b0;C step for 20 seconds that removes background fluorescence from primer-dimers. A melt curve analysis was produced at the end of the cycling to ensure the specificity of PCR product amplification and associated SYBR green fluorescence. Relative gene expression levels between mock-inoculated and inoculated cells were calculated using the Pfaffl method with potential variations in cDNA quantity between samples normalised to the transcript for ribosomal protein L13a (RPL13a) <a href="#pone.0009560-Pfaffl1" rid="pone.0009560-Pfaffl1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235220">[24]</a>. Serial dilutions of PCR product across 8 logs were used to determine the efficiency of PCR amplification for each primer set under the above conditions so that the relative quantitation could be adjusted as defined by the Pfaffl method.</p><p id="__p19" class="p p-last">A relative change in expression of two-fold was set as a threshold for determining whether differential expression of a gene had occurred. The <em>p</em> values associated with the fold-change in expression were calculated using a Students t-test on the real-time PCR C<sub>T</sub> values comparing triplicate mock-inoculated and HSV inoculated cells.</p></div><div id="s2f" class="sec"><h3 id="s2ftitle">Luciferase Assays</h3><p id="__p20" class="p p-first-last">An NF-&#x003ba;B reporter assay system was designed using a pGL4-NF&#x003ba;B construct (Promega). Quadruplicate repeats of the NF-&#x003ba;B binding consensus sequence <em class="gene">5&#x02032;-GGGAATTTCC-3&#x02032;</em> were excised from a p-NF-&#x003ba;B-Luc (Gift from Dr. Heike Laman, University of Cambridge) vector using KpnI and HindIII and ligated into the pGL4.20 vector multiple cloning site using the same restriction sites. pGL4.20 was chosen as it is optimized for more efficient expression in mammalian cells, compared to previous generations of luciferase constructs, and contains fewer transcription factor consensus sequences such that background luciferase expression is reduced. HFFs were electroporated in batches of 6&#x000d7;10<sup>5</sup> cells per cuvet (Amaxa) with 2 &#x000b5;g of pGL4-NF-&#x003ba;B, pooled together and aliquoted at 10<sup>5</sup> cells per well of a 24-well plate. After 48-hours recovery in supplemented media, the transfected HFFs were serum-starved for five days. HFFs were inoculated with 1000 particles/cell of &#x00394;gH HSV-1 and were lysed at the indicated time points in 100 &#x000b5;l passive lysis buffer (Promega) and 20 &#x000b5;l of lysate were examined for luciferase activity using 50 &#x000b5;l assay buffer (Promega).</p></div><div id="s2g" class="sec sec-last"><h3 id="s2gtitle">Western Blotting</h3><p id="__p21" class="p p-first-last">gD and the major tegument protein, VP16, were detected by immunoblotting using the monoclonal antibodies LP2 and LP1, respectively <a href="#pone.0009560-Minson1" rid="pone.0009560-Minson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235204">[25]</a>&#x02013;<a href="#pone.0009560-McLean1" rid="pone.0009560-McLean1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235205">[26]</a>. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were performed as described previously <a href="#pone.0009560-Browne2" rid="pone.0009560-Browne2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235162">[27]</a>.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Differential Cellular Gene Expression at Early Time-Points after Wild-Type HSV-1 Infection</h3><p id="__p22" class="p p-first">Signalling-specific microarrays were chosen as an initial route to identifying signalling pathways that may be stimulated early in HSV-1 infection, and more precisely, by virion binding. The Signal Transduction PathwayFinder cDNA array from Superarray incorporates 96 targets covering 19 associated signalling pathways, in addition to two negative controls corresponding to pUC18 plasmid DNA and a &#x02018;blank&#x02019; spot, as well as four positive controls representing the housekeeping genes for GAPDH, beta actin, cyclophilin A and ribosomal protein L13a.</p><p id="__p23">Serum-starved HFFs were inoculated with 1000 particles/cell of &#x00394;gB, &#x00394;gD or &#x00394;gH entry-defective HSV-1 virions. Total RNA was isolated immediately after inoculation, corresponding to 0 hpi, and 6 hpi. Changes in gene expression associated with the activation of signalling pathways were identified by comparison to the transcript abundance at 0 hpi. The results from duplicate experiments indicated that downstream gene targets of a number of signalling pathways are differentially expressed above the two-fold threshold after virion binding (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t001" rid-ob="ob-pone-0009560-t001" co-legend-rid=""><span>Table 1</span></a>). These preliminary results were then used as the basis of quantitative PCR studies.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0009560-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Fold change in gene expression after inoculation with entry-defective HSV-1.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037208044480" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">Description</td><td align="left" rowspan="1" colspan="1">&#x00394;gB</td><td align="left" rowspan="1" colspan="1">&#x00394;gD</td><td align="left" rowspan="1" colspan="1">&#x00394;gH</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>NF-KB</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2A1</td><td align="left" rowspan="1" colspan="1">hematopoietic BCL2-related protein A1</td><td align="left" rowspan="1" colspan="1">&#x02212;3.85 &#x0002a;</td><td align="left" rowspan="1" colspan="1">5.56</td><td align="left" rowspan="1" colspan="1">1.42</td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC1</td><td align="left" rowspan="1" colspan="1">baculoviral IAP repeat-containing 1</td><td align="left" rowspan="1" colspan="1">&#x02212;2.33</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12</td><td align="left" rowspan="1" colspan="1">&#x02212;3.13 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC2</td><td align="left" rowspan="1" colspan="1">baculoviral IAP repeat-containing 2</td><td align="left" rowspan="1" colspan="1">3.85</td><td align="left" rowspan="1" colspan="1">3.98</td><td align="left" rowspan="1" colspan="1">1.72</td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC3</td><td align="left" rowspan="1" colspan="1">baculoviral IAP repeat-containing 3</td><td align="left" rowspan="1" colspan="1">2.88</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">7.71 &#x0002a;&#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">CCL2</td><td align="left" rowspan="1" colspan="1">macrophage chemoattractant protein-1</td><td align="left" rowspan="1" colspan="1">2.32 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.34</td><td align="left" rowspan="1" colspan="1">2.13 &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">LTA</td><td align="left" rowspan="1" colspan="1">lymphotoxin alpha (TNF superfamily, member 1)</td><td align="left" rowspan="1" colspan="1">&#x02212;1.22</td><td align="left" rowspan="1" colspan="1">2.31</td><td align="left" rowspan="1" colspan="1">&#x02212;1.20</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKB1</td><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)</td><td align="left" rowspan="1" colspan="1">2.98 &#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.92</td><td align="left" rowspan="1" colspan="1">3.09 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKBIA</td><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha</td><td align="left" rowspan="1" colspan="1">&#x02212;1.19</td><td align="left" rowspan="1" colspan="1">1.23</td><td align="left" rowspan="1" colspan="1">2.54 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">PECAM1</td><td align="left" rowspan="1" colspan="1">platelet/endothelial cell adhesion molecule (CD31 antigen)</td><td align="left" rowspan="1" colspan="1">4.60 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">3.09 &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>JAK/STAT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A2M</td><td align="left" rowspan="1" colspan="1">alpha-2-macroglobulin</td><td align="left" rowspan="1" colspan="1">5.07 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.79</td><td align="left" rowspan="1" colspan="1">2.23</td></tr><tr><td align="left" rowspan="1" colspan="1">CSN2</td><td align="left" rowspan="1" colspan="1">casein beta</td><td align="left" rowspan="1" colspan="1">5.23 &#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">1.48</td></tr><tr><td align="left" rowspan="1" colspan="1">CXCL9</td><td align="left" rowspan="1" colspan="1">chemokine (C-X-C motif) ligand 9</td><td align="left" rowspan="1" colspan="1">2.22</td><td align="left" rowspan="1" colspan="1">&#x02212;1.59</td><td align="left" rowspan="1" colspan="1">1.06</td></tr><tr><td align="left" rowspan="1" colspan="1">IRF1</td><td align="left" rowspan="1" colspan="1">interferon regulatory factor-1</td><td align="left" rowspan="1" colspan="1">1.90</td><td align="left" rowspan="1" colspan="1">&#x02212;2.94</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP10</td><td align="left" rowspan="1" colspan="1">matrix metallopeptidase 10</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12</td><td align="left" rowspan="1" colspan="1">2.50</td></tr><tr><td align="left" rowspan="1" colspan="1">NOS2A</td><td align="left" rowspan="1" colspan="1">nitric oxide synthase 2A</td><td align="left" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1">1.21</td><td align="left" rowspan="1" colspan="1">8.01 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>PI3K/AKT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 2</td><td align="left" rowspan="1" colspan="1">3.54</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">1.86 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">CCND1</td><td align="left" rowspan="1" colspan="1">cyclin D1</td><td align="left" rowspan="1" colspan="1">1.54</td><td align="left" rowspan="1" colspan="1">&#x02212;9.09 &#x0002a;&#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">3.22 &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">FN1</td><td align="left" rowspan="1" colspan="1">fibronectin 1</td><td align="left" rowspan="1" colspan="1">1.50</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">6.28 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP7</td><td align="left" rowspan="1" colspan="1">matrix metallopeptidase 7</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">1.91</td><td align="left" rowspan="1" colspan="1">3.05 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">MYC</td><td align="left" rowspan="1" colspan="1">v-MYC myelocytomatosis viral oncogene homolog</td><td align="left" rowspan="1" colspan="1">2.83</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">4.55</td></tr><tr><td align="left" rowspan="1" colspan="1">WISP2</td><td align="left" rowspan="1" colspan="1">WNT1 inducible signaling pathway protein 2</td><td align="left" rowspan="1" colspan="1">&#x02212;7.69 &#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">1.50</td><td align="left" rowspan="1" colspan="1">&#x02212;4.55 &#x0002a;&#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Jak/Src</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 2</td><td align="left" rowspan="1" colspan="1">3.54</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">1.86 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2L1</td><td align="left" rowspan="1" colspan="1">BCL2-like 1; Bcl-X</td><td align="left" rowspan="1" colspan="1">&#x02212;4.92</td><td align="left" rowspan="1" colspan="1">&#x02212;5.00 &#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;3.33</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>p53</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">GADD45A</td><td align="left" rowspan="1" colspan="1">growth arrest and DNA-damage-inducible, alpha</td><td align="left" rowspan="1" colspan="1">5.22 &#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.15</td><td align="left" rowspan="1" colspan="1">1.96</td></tr><tr><td align="left" rowspan="1" colspan="1">IGFBP3</td><td align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 3</td><td align="left" rowspan="1" colspan="1">&#x02212;6.67 &#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.04</td><td align="left" rowspan="1" colspan="1">1.18 &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">MDM2</td><td align="left" rowspan="1" colspan="1">Mdm2 p53 binding protein homolog (mouse)</td><td align="left" rowspan="1" colspan="1">6.83 &#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.82</td><td align="left" rowspan="1" colspan="1">2.89</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Phospholipase C</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">EGR1</td><td align="left" rowspan="1" colspan="1">early growth response 1</td><td align="left" rowspan="1" colspan="1">&#x02212;2.70</td><td align="left" rowspan="1" colspan="1">&#x02212;2.50 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.09</td></tr><tr><td align="left" rowspan="1" colspan="1">FAS</td><td align="left" rowspan="1" colspan="1">fas (TNF receptor superfamily, member 6)</td><td align="left" rowspan="1" colspan="1">&#x02212;2.38</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">&#x02212;2.63 &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">FOS</td><td align="left" rowspan="1" colspan="1">FBJ murine osteosarcoma viral oncogene homolog</td><td align="left" rowspan="1" colspan="1">&#x02212;2.78 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.56</td><td align="left" rowspan="1" colspan="1">&#x02212;1.59</td></tr><tr><td align="left" rowspan="1" colspan="1">JUNB</td><td align="left" rowspan="1" colspan="1">jun B proto-oncogene</td><td align="left" rowspan="1" colspan="1">&#x02212;1.01</td><td align="left" rowspan="1" colspan="1">&#x02212;2.56</td><td align="left" rowspan="1" colspan="1">&#x02212;1.33</td></tr><tr><td align="left" rowspan="1" colspan="1">PTGS2</td><td align="left" rowspan="1" colspan="1">rostaglandin-endoperoxide synthase 2</td><td align="left" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1">1.21</td><td align="left" rowspan="1" colspan="1">8.01</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>TGF-&#x003b2;</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">CDKN1A</td><td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 1A</td><td align="left" rowspan="1" colspan="1">1.12 &#x0002a;</td><td align="left" rowspan="1" colspan="1">4.01 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.10</td></tr><tr><td align="left" rowspan="1" colspan="1">CDKN2A</td><td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 2A</td><td align="left" rowspan="1" colspan="1">1.89</td><td align="left" rowspan="1" colspan="1">1.35</td><td align="left" rowspan="1" colspan="1">&#x02212;4.17 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">CDKN2B</td><td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 2B</td><td align="left" rowspan="1" colspan="1">&#x02212;1.19</td><td align="left" rowspan="1" colspan="1">2.72</td><td align="left" rowspan="1" colspan="1">&#x02212;2.27</td></tr><tr><td align="left" rowspan="1" colspan="1">CDKN2D</td><td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 2D</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">&#x02212;4.55 &#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Retinoic Acid</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">CDX1</td><td align="left" rowspan="1" colspan="1">caudal type homeobox 1</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">1.09</td></tr><tr><td align="left" rowspan="1" colspan="1">CTSD</td><td align="left" rowspan="1" colspan="1">cathepsin D</td><td align="left" rowspan="1" colspan="1">&#x02212;1.05</td><td align="left" rowspan="1" colspan="1">&#x02212;3.70</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12</td></tr><tr><td align="left" rowspan="1" colspan="1">EN1</td><td align="left" rowspan="1" colspan="1">engrailed homeobox 1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.10</td><td align="left" rowspan="1" colspan="1">&#x02212;2.22</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">RBP1</td><td align="left" rowspan="1" colspan="1">retinol binding protein 1, cellular</td><td align="left" rowspan="1" colspan="1">1.68</td><td align="left" rowspan="1" colspan="1">&#x02212;3.03 &#x0002a;</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Androgen</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">CDK2</td><td align="left" rowspan="1" colspan="1">cyclin-dependent kinase 2</td><td align="left" rowspan="1" colspan="1">3.86</td><td align="left" rowspan="1" colspan="1">&#x02212;1.45</td><td align="left" rowspan="1" colspan="1">3.44 &#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">KLK2</td><td align="left" rowspan="1" colspan="1">kallikrein-related peptidase 2</td><td align="left" rowspan="1" colspan="1">6.83 &#x0002a;&#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;1.82</td><td align="left" rowspan="1" colspan="1">2.89</td></tr><tr><td align="left" rowspan="1" colspan="1">TMEPA1</td><td align="left" rowspan="1" colspan="1">prostate transmembrane protein, androgen induced 1</td><td align="left" rowspan="1" colspan="1">3.69</td><td align="left" rowspan="1" colspan="1">1.41</td><td align="left" rowspan="1" colspan="1">&#x02212;3.13 &#x0002a;&#x0002a;&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Hedgehog</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BMP4</td><td align="left" rowspan="1" colspan="1">bone morphogenetic protein 4</td><td align="left" rowspan="1" colspan="1">&#x02212;2.22 &#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;2.38</td><td align="left" rowspan="1" colspan="1">&#x02212;1.67</td></tr></tbody></table></div><div id="largeobj_idm140037208044480" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/table/pone-0009560-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><sup></sup>HFFs were stimulated with 1000 particles/cell of &#x00394;gB, &#x00394;gD or &#x00394;gH HSV-1 for six hours and a cDNA microarray corresponding to targets of 19 signalling pathways was used to detect changes in cellular gene expression when compared to mock-infected. Infections and mock infections were carried out in duplicate. A number of signalling pathways were shown to be stimulated by one or more of the entry-defective mutants. These data were used to independently verify changes in expression using real-time PCR.</div></div></div><p id="__p25" class="p">Using the same methodology, serum-starved HFF cells were exposed to 1000 particles per cell of virions lacking either gD, gB or gH and RNA was extracted for cDNA synthesis immediately (0 h) or after 6 h. <a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a> gives the results of three independent experiments for those genes that were differentially expressed between 0 h and 6 h post treatment and is compared to the initial microarray results in <a href="/pmc/articles/PMC2832691/table/pone-0009560-t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t003" rid-ob="ob-pone-0009560-t003" co-legend-rid=""><span>Table 3</span></a>. It is striking that in virtually every instance where gene expression is modified by virion binding, gD appears to be the key effector. Virions lacking gH or gB had were capable of altering cellular gene expression while those lacking gD had no significant effect. The results can be summarised as follows.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0009560-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Independent confirmation of microarray data by real-time PCR.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037113088528" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">Description</td><td align="left" rowspan="1" colspan="1">&#x00394;gB</td><td align="left" rowspan="1" colspan="1">&#x00394;gD</td><td align="left" rowspan="1" colspan="1">&#x00394;gH</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>NF-KB</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC2</td><td align="left" rowspan="1" colspan="1">baculoviral IAP repeat-containing 2</td><td align="left" rowspan="1" colspan="1">3.66 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">2.92</td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC3</td><td align="left" rowspan="1" colspan="1">baculoviral IAP repeat-containing 3</td><td align="left" rowspan="1" colspan="1">4.45 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.27</td><td align="left" rowspan="1" colspan="1">3.71 <sup>&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">CCL2</td><td align="left" rowspan="1" colspan="1">macrophage chemoattractant protein-1</td><td align="left" rowspan="1" colspan="1">2.09</td><td align="left" rowspan="1" colspan="1">&#x02212;1.51</td><td align="left" rowspan="1" colspan="1">3.16 <sup>&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKB1</td><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)</td><td align="left" rowspan="1" colspan="1">3.54 <sup>&#x0002a;&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.13</td><td align="left" rowspan="1" colspan="1">2.61 <sup>&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKBIA</td><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha</td><td align="left" rowspan="1" colspan="1">2.35 <sup>&#x0002a;&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">1.48 <sup>&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKBIB</td><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta</td><td align="left" rowspan="1" colspan="1">2.72 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">1.40</td></tr><tr><td align="left" rowspan="1" colspan="1">PECAM1</td><td align="left" rowspan="1" colspan="1">platelet/endothelial cell adhesion molecule (CD31 antigen)</td><td align="left" rowspan="1" colspan="1">3.49 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.22</td><td align="left" rowspan="1" colspan="1">4.44 <sup>&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">REL</td><td align="left" rowspan="1" colspan="1">v-REL reticuloendotheliosis viral oncogene homolog (C-REL)</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">&#x02212;1.25</td><td align="left" rowspan="1" colspan="1">2.63 <sup>&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>JAK/STAT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A2M</td><td align="left" rowspan="1" colspan="1">alpha-2-macroglobulin</td><td align="left" rowspan="1" colspan="1">3.54 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.77</td><td align="left" rowspan="1" colspan="1">2.55 <sup>&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP10</td><td align="left" rowspan="1" colspan="1">matrix metallopeptidase 10</td><td align="left" rowspan="1" colspan="1">2.87 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.52</td><td align="left" rowspan="1" colspan="1">2.62 <sup>&#x0002a;&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">NOS2A</td><td align="left" rowspan="1" colspan="1">nitric oxide synthase 2A</td><td align="left" rowspan="1" colspan="1">5.00 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.09</td><td align="left" rowspan="1" colspan="1">4.41 <sup>&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>PI3K/AKT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 2</td><td align="left" rowspan="1" colspan="1">2.86 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;2.33 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP7</td><td align="left" rowspan="1" colspan="1">matrix metallopeptidase 7</td><td align="left" rowspan="1" colspan="1">3.67 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.03</td><td align="left" rowspan="1" colspan="1">2.04</td></tr><tr><td align="left" rowspan="1" colspan="1">MYC</td><td align="left" rowspan="1" colspan="1">v-MYC myelocytomatosis viral oncogene homolog</td><td align="left" rowspan="1" colspan="1">4.53 <sup>&#x0002a;&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.04</td><td align="left" rowspan="1" colspan="1">2.67 <sup>&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Jak/Src</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 2</td><td align="left" rowspan="1" colspan="1">2.86 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;2.33 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2L1</td><td align="left" rowspan="1" colspan="1">BCL2-like 1; Bcl-X</td><td align="left" rowspan="1" colspan="1">2.56 <sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.92 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">2.09 <sup>&#x0002a;&#x0002a;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Androgen</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">CDK2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">3.01<sup>&#x0002a;&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">3.08<sup>&#x0002a;&#x0002a;</sup>\n</td></tr></tbody></table></div><div id="largeobj_idm140037113088528" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/table/pone-0009560-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt102"><sup></sup>Note.</div><div id="nt103"><sup></sup>&#x0002a;p&#x0003c;0.05.</div><div id="nt104"><sup></sup>&#x0002a;&#x0002a;p&#x02264;0.01.</div><div id="nt105"><sup></sup>&#x0002a;&#x0002a;&#x0002a;p&#x02264;0.001.</div><div id="nt106"><sup></sup>HFFs were stimulated with 1000 particles/cell of entry-defective HSV-1 and changes in cellular gene expression were detected by real-time PCR at 6 hours post-inoculation. NF-&#x003ba;B responsive genes appear to be up-regulated by binding of either &#x00394;gB or &#x00394;gH virions to the cell. The increase in NF-&#x003ba;B-associated transcripts appears specific as not all targets were differentially regulated. A similar pattern of gene expression is seen for Jak/Stat pathway targets in that &#x00394;gD virions appear to be unable to stimulate signalling whereas &#x00394;gB and &#x00394;gH binding can. MMP7 is only associated with the PI3 Kinase/Akt pathway and coupled with the up-regulation of BCL2, CCND1 and MYC, it would appear that binding may be sufficient to also stimulate this pathway, although not by virions lacking in gD. The Jak/Src pathway only contains two targets on the signalling specific microarray, one of which, BCL2, was associated with other pathways.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0009560-t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Comparison of microarray with real-time PCR data for differentially expressed genes.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037113618160" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td colspan="2" align="left" rowspan="1">&#x00394;gB</td><td colspan="2" align="left" rowspan="1">&#x00394;gD</td><td colspan="2" align="left" rowspan="1">&#x00394;gH</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">Real-Time</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">Real-Time</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">Real-Time</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>NF-KB</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC2</td><td align="left" rowspan="1" colspan="1">3.66</td><td align="left" rowspan="1" colspan="1">3.85</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">3.98</td><td align="left" rowspan="1" colspan="1">2.92</td><td align="left" rowspan="1" colspan="1">&#x02212;1.01</td></tr><tr><td align="left" rowspan="1" colspan="1">BIRC3</td><td align="left" rowspan="1" colspan="1">4.45</td><td align="left" rowspan="1" colspan="1">2.88</td><td align="left" rowspan="1" colspan="1">1.27</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">3.71</td><td align="left" rowspan="1" colspan="1">7.71</td></tr><tr><td align="left" rowspan="1" colspan="1">CCL2</td><td align="left" rowspan="1" colspan="1">2.09</td><td align="left" rowspan="1" colspan="1">2.32</td><td align="left" rowspan="1" colspan="1">&#x02212;1.51</td><td align="left" rowspan="1" colspan="1">1.34</td><td align="left" rowspan="1" colspan="1">3.16</td><td align="left" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKB1</td><td align="left" rowspan="1" colspan="1">3.54</td><td align="left" rowspan="1" colspan="1">2.98</td><td align="left" rowspan="1" colspan="1">1.13</td><td align="left" rowspan="1" colspan="1">&#x02212;1.92</td><td align="left" rowspan="1" colspan="1">2.61</td><td align="left" rowspan="1" colspan="1">3.09</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKBIA</td><td align="left" rowspan="1" colspan="1">2.35</td><td align="left" rowspan="1" colspan="1">&#x02212;1.19</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">1.23</td><td align="left" rowspan="1" colspan="1">1.48</td><td align="left" rowspan="1" colspan="1">2.54</td></tr><tr><td align="left" rowspan="1" colspan="1">NFKBIB</td><td align="left" rowspan="1" colspan="1">2.72</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.40</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">PECAM1</td><td align="left" rowspan="1" colspan="1">3.49</td><td align="left" rowspan="1" colspan="1">4.60</td><td align="left" rowspan="1" colspan="1">1.22</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">4.44</td><td align="left" rowspan="1" colspan="1">3.09</td></tr><tr><td align="left" rowspan="1" colspan="1">REL</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x02212;1.25</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">2.63</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>JAK/STAT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A2M</td><td align="left" rowspan="1" colspan="1">3.54</td><td align="left" rowspan="1" colspan="1">5.07</td><td align="left" rowspan="1" colspan="1">1.77</td><td align="left" rowspan="1" colspan="1">1.79</td><td align="left" rowspan="1" colspan="1">2.55</td><td align="left" rowspan="1" colspan="1">2.23</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP10</td><td align="left" rowspan="1" colspan="1">2.87</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">1.52</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12</td><td align="left" rowspan="1" colspan="1">2.62</td><td align="left" rowspan="1" colspan="1">2.50</td></tr><tr><td align="left" rowspan="1" colspan="1">NOS2A</td><td align="left" rowspan="1" colspan="1">5.00</td><td align="left" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1">&#x02212;1.09</td><td align="left" rowspan="1" colspan="1">1.21</td><td align="left" rowspan="1" colspan="1">4.41</td><td align="left" rowspan="1" colspan="1">8.01</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>PI3K/AKT</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">2.86</td><td align="left" rowspan="1" colspan="1">1.86</td><td align="left" rowspan="1" colspan="1">&#x02212;2.33</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1">1.86</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP7</td><td align="left" rowspan="1" colspan="1">3.67</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">&#x02212;1.03</td><td align="left" rowspan="1" colspan="1">1.91</td><td align="left" rowspan="1" colspan="1">2.04</td><td align="left" rowspan="1" colspan="1">3.05</td></tr><tr><td align="left" rowspan="1" colspan="1">MYC</td><td align="left" rowspan="1" colspan="1">4.53</td><td align="left" rowspan="1" colspan="1">2.83</td><td align="left" rowspan="1" colspan="1">&#x02212;1.04</td><td align="left" rowspan="1" colspan="1">2.85</td><td align="left" rowspan="1" colspan="1">2.67</td><td align="left" rowspan="1" colspan="1">2.48</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Jak/Src</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2</td><td align="left" rowspan="1" colspan="1">2.86</td><td align="left" rowspan="1" colspan="1">1.86</td><td align="left" rowspan="1" colspan="1">&#x02212;2.33</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1">1.86</td></tr><tr><td align="left" rowspan="1" colspan="1">BCL2L1</td><td align="left" rowspan="1" colspan="1">2.56</td><td align="left" rowspan="1" colspan="1">1.42</td><td align="left" rowspan="1" colspan="1">&#x02212;1.92</td><td align="left" rowspan="1" colspan="1">&#x02212;5.00</td><td align="left" rowspan="1" colspan="1">2.09</td><td align="left" rowspan="1" colspan="1">&#x02212;1.18</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Androgen</strong>\n</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">CDK2</td><td align="left" rowspan="1" colspan="1">3.01</td><td align="left" rowspan="1" colspan="1">3.86</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">&#x02212;1.45</td><td align="left" rowspan="1" colspan="1">3.08</td><td align="left" rowspan="1" colspan="1">3.44</td></tr></tbody></table></div><div id="largeobj_idm140037113618160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/table/pone-0009560-t003/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt107"><sup></sup>There was a degree of correlation between the change in expression determined by microarray studies and those confirmed by real-time PCR, particularly for genes under the control of NF-&#x003ba;B. Note: <em>rel</em> and <em>nfkbib</em> were not present on the original signalling-specific microarray, but were included in the real-time analysis, as they are known to be up-regulated as part of the NF-&#x003ba;B feedback mechanism.</div></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">JAK/STAT and JAK/Src Pathways</h3><p id="__p32" class="p p-first-last">The JAK/STAT and related JAK/Src pathway show a similar response to that seen for NF-&#x003ba;B. Of the JAK/STAT-responsive genes, only NOS2A is regulated by more than one pathway, with &#x00394;gB and &#x00394;gH virions inducing their transcription and &#x00394;gD particles having no significant effect (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a>). Although the JAK/Src pathway has only two targets on the signalling microarrays - upon which the real-time PCR experiments were based - BCL2L1 is unique to the pathway, with BCL2 expression regulated by multiple signalling routes. Interestingly, while &#x00394;gB and &#x00394;gH virions up-regulated BCL2 and BCL2L1, &#x00394;gD virus particles appeared to down-regulate both targets by a significant amount.</p></div><div id="s3c" class="sec"><h3 id="s3ctitle">PI3K/Akt Pathway</h3><p id="__p33" class="p p-first-last">Induction of this pathway may be responsible for the upregulation of CCND1, MYC, BCL2 and MMP7 after inoculation with &#x00394;gB and &#x00394;gH but not &#x00394;gD HSV-1 (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a>). Differential expression of CCND1 and MYC can be regulated by the Wnt and PI3K signalling pathways, with MYC also being controlled by Protein Kinase C. The up-regulation of MMP7, which is the only target unique to the PI3K pathway that is differentially expressed, highlights the potential crosstalk between signalling pathways and cannot exclude the involvement of PI3 kinase signalling as a pathway leading to transcription of all four cellular genes.</p></div><div id="s3d" class="sec"><h3 id="s3dtitle">NF-&#x003ba;B Pathway</h3><p id="__p34" class="p p-first">Both &#x00394;gB and &#x00394;gH virions are capable of stimulating an NF-kB response (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a>), a result that correlates with the preliminary microarray data (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t001" rid-ob="ob-pone-0009560-t001" co-legend-rid=""><span>Table 1</span></a>). Transcripts for both BIRC-2 and BIRC-3 are increased above the two-fold threshold after inoculation with &#x00394;gB and &#x00394;gH HSV-1 but not &#x00394;gD. There appears to be no change in BIRC-1 expression after inoculation with any of the three entry-defective mutants. Components of the NF-&#x003ba;B transcriptional complex, NFKB1 and REL, showed similar levels of increased transcription after binding by &#x00394;gB and &#x00394;gH virions, a response that was absent in cells stimulated with gD-deficient virions. Two markers of inflammation, CCL2 and PECAM1, also showed a significant change in gene expression at 6 hpi with entry-defective HSV-1 lacking gB or gH but not gD.</p><p id="__p35" class="p p-last">The downstream signalling appears specific as not all NF-&#x003ba;B targets were up-regulated. The NF-&#x003ba;B repressors, NFKBIA and NFKBIB, were only up-regulated by &#x00394;gB virion binding (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a>).</p></div><div id="s3e" class="sec"><h3 id="s3etitle">Kinetics of NF-&#x003ba;B Activation</h3><p id="__p36" class="p p-first">To confirm that virion binding induces NF-&#x003ba;B and to examine the kinetics, an NF-&#x003ba;B promoter-driven luciferase construct was transfected into HFF cells and cells were treated with &#x00394;gH virions (1000 particles per cell) or were mock-treated. Cells were harvested every hour until 9 hr post treatment, lysed and assayed for luciferase activity in triplicate. <a href="/pmc/articles/PMC2832691/figure/pone-0009560-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g001" rid-ob="ob-pone-0009560-g001" co-legend-rid="lgnd_pone-0009560-g001"><span>Figure 1(a)</span></a> shows the fold-change in luciferase activity of those HFFs inoculated with &#x00394;gH in comparison to mock-inoculated cells at the same time point. Biological duplicates of the inoculations were performed with the lysates used in triplicate reporter assays. At 1 hpi, there is an average of 2.4 fold change in luciferase activity from the NF-&#x003ba;B reporter, rising to 3.5 at 2 hpi and is maintained through to 3 hpi whereby it drops to 1.8 at 4 hpi, which correlates with the half-life of luciferase <a href="#pone.0009560-Thompson1" rid="pone.0009560-Thompson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235199">[28]</a>. By 5 hpi, and until 9 hpi, luciferase activity drops to baseline levels at, or near, 1-fold change. Error bars represent the standard error across the six readings taken from technical triplicates on biological duplicates.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0009560-g001" co-legend-rid="lgnd_pone-0009560-g001"><a href="/pmc/articles/PMC2832691/figure/pone-0009560-g001/" target="figure" rid-figpopup="pone-0009560-g001" rid-ob="ob-pone-0009560-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037170127904" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2832691_pone.0009560.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0009560.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2832691/bin/pone.0009560.g001.jpg" /></a></div><div id="largeobj_idm140037170127904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/figure/pone-0009560-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0009560-g001"><div><a class="figpopup" href="/pmc/articles/PMC2832691/figure/pone-0009560-g001/" target="figure" rid-figpopup="pone-0009560-g001" rid-ob="ob-pone-0009560-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Kinetics of signalling activation.</strong><p id="__p37">(A) An NF-&#x003ba;B luciferase construct was transfected into HFF, which were left to serum-starve for five days. Cells were then mock-infected or inoculated with 1000 particles/cell of entry-defective &#x00394;gH HSV-1 then lysed at the indicated times and assayed for luciferase activity. Error bars are the &#x0002b;/&#x02212; standard error across triplicate luciferase assays for each biological duplicate. (B) NF-&#x003ba;B, JAK/STAT, JAK/Src and PI3K/Akt-responsive genes that were previously shown to be differentially expressed at 6 hours post-inoculation with &#x00394;gB and &#x00394;gH virions were examined for changes in expression at two-and-a-half hours after inoculation with 1000 particles/cell of &#x00394;gH virions. The induction of JAK/STAT and PI3K/Akt targets is not significantly up-regulated above the two-fold threshold by two-and-a-half hours post-inoculation. A number of NF-&#x003ba;B-associated transcripts are significantly up-regulated, with <em>ccl2</em> showing a far greater induction at two-and-a-half hours than six hours. Both JAK/Src targets, <em>bcl2</em> and <em>bcl2l1</em> are induced to similar levels found at six hours post-inoculation. Error bars are the &#x0002b;/&#x02212; standard error across triplicate biological replicates.</p></div></div></div><p id="__p38" class="p p-last">As induction of the NF-&#x003ba;B reporter construct occurred within one hour of inoculation with &#x00394;gH virions and peaked at around two-and-a-half hours post-inoculation, then the transcripts previously shown in <a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a> to be up-regulated as a result of &#x00394;gH virions binding were examined for changes in transcript levels at two-and-a-half hours after inoculation with &#x00394;gH. <a href="/pmc/articles/PMC2832691/figure/pone-0009560-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g001" rid-ob="ob-pone-0009560-g001" co-legend-rid="lgnd_pone-0009560-g001"><span>Figure 1(b)</span></a> compares expression levels at two-and-a-half and six hours post-inoculation. Transcripts for the NF-&#x003ba;B-responsive chemokine CCL2 were up-regulated to a greater degree at two-and-a-half hours than at six hours post-inoculation. Of the NF-&#x003ba;B-responsive genes, REL transcription was induced to a higher level whereas PECAM1 transcript abundance was reduced in comparison to six hours. Although JAK/STAT-responsive targets were not differentially expressed by two-and-a-half hours, the JAK/Src targets BCL2 and BCL2L1 were up-regulated above the two-fold arbitrary threshold to similar transcript levels that were seen at six hours post-inoculation.</p></div><div id="s3f" class="sec"><h3 id="s3ftitle">Interferogenic Capacity of Entry-Defective Virions</h3><p id="__p39" class="p p-first">The initial microarray screen was uninformative with respect to interferon signalling, but this was of interest because soluble gD has been reported to induce IFN <a href="#pone.0009560-Ankel1" rid="pone.0009560-Ankel1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235219">[29]</a>, while, in contrast, ISG induction is reported to require virion entry but not <em>de novo</em> protein synthesis <sup><a href="#pone.0009560-Preston1" rid="pone.0009560-Preston1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235161">[30]</a></sup>. Primers were designed to Type I interferons, &#x003b1; (IFNA1) and &#x000ae; (IFNB1), and the newly designated Type III interferon &#x003bb; (IL29). Human fibroblasts do not produce interferon gamma. Additionally, the cDNA preparation was used to identify any change in the abundance of ISGs. Both &#x00394;gB and &#x00394;gH virions were able to stimulate the up-regulation of IFN-&#x003b1; expression 2.81 fold and 2.34 fold, respectively, with a high degree of statistical significance (p&#x02264;0.05) (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t004/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t004" rid-ob="ob-pone-0009560-t004" co-legend-rid=""><span>Table 4</span></a>). HSV-1 particles lacking gD were unable to do so, with a fold change of &#x02212;1.11 and a p&#x0200a;=&#x0200a;0.15 (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t004/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t004" rid-ob="ob-pone-0009560-t004" co-legend-rid=""><span>Table 4</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0009560-t004"><h3>Table 4</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Interferon response to HSV-1 virion binding.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037134750272" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Description</td><td align="left" rowspan="1" colspan="1">&#x00394;gB</td><td align="left" rowspan="1" colspan="1">&#x00394;gD</td><td align="left" rowspan="1" colspan="1">&#x00394;gH</td><td align="left" rowspan="1" colspan="1">MOI 0.01</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IFNA1</td><td align="left" rowspan="1" colspan="1">interferon, alpha 1</td><td align="left" rowspan="1" colspan="1">2.63 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.11</td><td align="left" rowspan="1" colspan="1">2.25 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.23</td></tr><tr><td align="left" rowspan="1" colspan="1">IFNB1</td><td align="left" rowspan="1" colspan="1">interferon, beta 1, fibroblast</td><td align="left" rowspan="1" colspan="1">3.01 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">2.15 <sup>&#x0002a;</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x02212;1.07</td><td align="left" rowspan="1" colspan="1">&#x02212;1.18</td></tr><tr><td align="left" rowspan="1" colspan="1">IL29</td><td align="left" rowspan="1" colspan="1">interleukin 29 (interferon, lambda 1)</td><td align="left" rowspan="1" colspan="1">1.51</td><td align="left" rowspan="1" colspan="1">&#x02212;1.33</td><td align="left" rowspan="1" colspan="1">&#x02212;1.69</td><td align="left" rowspan="1" colspan="1">1.11</td></tr><tr><td align="left" rowspan="1" colspan="1">ISG54</td><td align="left" rowspan="1" colspan="1">IFN-induced protein 54</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">1.57</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">&#x02212;1.45</td></tr><tr><td align="left" rowspan="1" colspan="1">IRF1</td><td align="left" rowspan="1" colspan="1">interferon regulatory factor 1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.21</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">1.36</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">IRF3</td><td align="left" rowspan="1" colspan="1">interferon regulatory factor 3</td><td align="left" rowspan="1" colspan="1">1.14</td><td align="left" rowspan="1" colspan="1">&#x02212;1.10</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">1.08</td></tr><tr><td align="left" rowspan="1" colspan="1">IRF7</td><td align="left" rowspan="1" colspan="1">interferon regulatory factor 7</td><td align="left" rowspan="1" colspan="1">1.19</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">&#x02212;1.05</td><td align="left" rowspan="1" colspan="1">&#x02212;1.23</td></tr><tr><td align="left" rowspan="1" colspan="1">IRF9</td><td align="left" rowspan="1" colspan="1">interferon regulatory factor 9</td><td align="left" rowspan="1" colspan="1">&#x02212;1.23</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">1.44</td><td align="left" rowspan="1" colspan="1">&#x02212;1.33</td></tr></tbody></table></div><div id="largeobj_idm140037134750272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/table/pone-0009560-t004/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt108"><sup></sup>Note.</div><div id="nt109"><sup></sup>&#x0002a;p&#x0003c;0.05.</div><div id="nt110"><sup></sup>Binding by &#x00394;gB and &#x00394;gH virions up-regulated the expression of IFN-&#x003b1; whereas &#x00394;gB and &#x00394;gD virions were able to stimulate an increase in IFN-&#x003b2;. Infection with wild-type HSV-1 at an MOI of 0.01 was insufficient to cause similar increases in interferon expression. Interferon-stimulated genes were not up-regulated above the two-fold threshold by binding of any of the entry-defective HSV-1 mutants. Wild-type infection at a low MOI was also insufficient to cause in increase in ISG transcripts when compared to mock-infected cells.</div></div></div><p id="__p43">IFN-&#x000ae; transcript levels were up-regulated 2.22 fold by &#x00394;gB virions and 2.06 fold (p&#x0200a;=&#x0200a;0.01) by &#x00394;gD virions, again with a high degree of statistical significance. Inoculation with virus particles lacking gH led to a &#x02212;1.07 fold change (p&#x0200a;=&#x0200a;0.44) in IFN-&#x000ae; expression when compared to mock-infected cultures. All three entry-defective mutants were unable to modulate the expression of IFN-&#x003bb; above the arbitrary two-fold threshold.</p><p id="__p44">The glycosylation status of IFN-inducing viral glycoproteins is a potential determinant of induction efficacy <a href="#pone.0009560-Paludan1" rid="pone.0009560-Paludan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235159">[22]</a>\n<a href="#pone.0009560-Laude1" rid="pone.0009560-Laude1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235163">[31]</a>. HSV-1 gD has three potential N-glycosylation sites but lacks O-linked glycosylation. &#x00394;gH virions, that retain expression of gD, were treated with the endoglycosidase, PNGase F, which removes N-linked sugars. A long incubation was required as the denaturing buffer was excluded from the reaction to avoid conformational changes that might abrogate virion binding. As previously shown, wild-type virions treated in a similar manner retained infectivity (<a href="#pone.0009560.s003" rid="pone.0009560.s003" class=" supplementary-material">Figure S1</a>) <a href="#pone.0009560-Paludan1" rid="pone.0009560-Paludan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235176">[22]</a>.</p><p id="__p45">HFF were inoculated as above with &#x00394;gH virions that had been incubated for 18 hrs in the presence or absence of PNGase. Glycosylated and deglycosylated &#x00394;gH virions stimulated a 2.23 and 2.28 fold increase in IFN-&#x003b1; transcription, respectively. These results suggest that glycosylation has no impact on the interferogenic properties of &#x00394;gH virions, unlike the glycoproteins of MHV and TGEV, which appear to stimulate Type I IFN through a lectin-like action, HSV-1 gD may trigger IFN up-regulation through a different mechanism, possibly analogous to that used to stimulate other signalling pathways.</p><p id="__p46">Five interferon-stimulated genes were chosen to examine whether they were differentially expressed by virion binding. IFN-induced protein 54 (ISG54) transcripts are routinely used as a marker of ISG induction. Binding by &#x00394;gB, &#x00394;gD or &#x00394;gH virions was insufficient to cause changes in the transcript abundance of interferon regulatory factor-1, -3, -7, -9 or ISG54 (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t004/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t004" rid-ob="ob-pone-0009560-t004" co-legend-rid=""><span>Table 4</span></a>).</p><p id="__p47" class="p p-last">To ensure that these observations could not result from a background of infection by competent virus, parallel cultures were infected with wild type virus at an MOI of 0.01, a level of infection some tenfold higher than would result from the &#x02018;worst case&#x02019; scenario using preparations of entry defective virions (see <a href="#s2" rid="s2" class=" sec">Methods</a>). These cultures exhibited no induction of IFN or ISGs (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t004/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t004" rid-ob="ob-pone-0009560-t004" co-legend-rid=""><span>Table 4</span></a>).</p></div><div id="s3g" class="sec sec-last"><h3 id="s3gtitle">Effects of &#x00394;gH Virion Multiplicity on Stimulating Signalling</h3><p id="__p48" class="p p-first">All the experimental work described above was performed using treatments with 1000 virus particles per cell, a condition that would be unlikely to pertain in natural primary infections. To establish whether much lower virion numbers would be effective, HFFs were serum-starved for five days then mock-inoculated or inoculated with 1, 10, 100 or 1000 particles per cell of &#x00394;gH HSV-1 for six hours. Infections were carried out in duplicate with mock- inoculated controls that received an equivalent volume of PBS. Total RNA was purified and reverse transcribed, with the cDNA from each duplicate inoculation used in triplicate for real-time PCR.</p><p id="__p49">The NF-&#x003ba;B responsive genes NFKB1, REL and CCL2, in addition to the JAK/STAT target NOS2A, were used as they had previously been shown to be differentially expressed after inoculation with 1000 particles/cell of &#x00394;gH HSV-1. Recalling that the more abundant a transcript the fewer number of cycles it takes to cross a threshold set in the exponential phase of PCR product accumulation (the C<sub>T</sub> value), <a href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002" co-legend-rid="lgnd_pone-0009560-g002"><span>Figure 2</span></a> plots the &#x00394;C<sub>T</sub> value on the y-axis, (i.e. the C<sub>T</sub> value for the gene of interest after normalisation against the RPL13) against the multiplicity of infection on the x-axis. As the multiplicity of &#x00394;gH increases the C<sub>T</sub> value decreases, indicating an increase in the abundance of transcripts for all three NF-&#x003ba;B targets (<a href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002" co-legend-rid="lgnd_pone-0009560-g002"><span>Figure 2(a)</span></a>). A logarithmic regression analysis across three logs of multiplicity show a high correlation between the four C<sub>T</sub> values for each transcript with r<sup>2</sup>&#x0003e;0.98. Similarly for the JAK/STAT responsive target NOS2A there are almost two cycles of a difference between the level of transcripts after infection with 1 particle/cell compared to 1000 particles/cell (<a href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002" co-legend-rid="lgnd_pone-0009560-g002"><span>Figure 2(b)</span></a>). This larger response than those for NF-&#x003ba;B responsive genes is indicative of the different level of induction shown with previous real-time PCR analysis of these transcripts (<a href="/pmc/articles/PMC2832691/table/pone-0009560-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0009560-t002" rid-ob="ob-pone-0009560-t002" co-legend-rid=""><span>Table 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0009560-g002" co-legend-rid="lgnd_pone-0009560-g002"><a href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037115987024" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2832691_pone.0009560.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0009560.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2832691/bin/pone.0009560.g002.jpg" /></a></div><div id="largeobj_idm140037115987024" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0009560-g002"><div><a class="figpopup" href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of virion multiplicity on gene transcription.</strong><p id="__p50">Low multiplicities of infection, which may represent physiological conditions, were sufficient to trigger an intracellular signalling response. (A) As the number of inoculated &#x00394;gH particles increases, the number of cycles taken to reach the cycle threshold decreases for the NF-KB-responsive genes <em>nfkbi</em>, <em>ccl2</em> and <em>rel</em>, indicating an increased abundance of transcript. (B) A similar dose response is seen for the JAK/STAT target <em>nos2a</em>. Error bars are the &#x0002b;/&#x02212; standard error across triplicate biological replicates.</p></div></div></div><p id="__p51" class="p p-last">Arrows in <a href="/pmc/articles/PMC2832691/figure/pone-0009560-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g002" rid-ob="ob-pone-0009560-g002" co-legend-rid="lgnd_pone-0009560-g002"><span>Figure 2</span></a> indicate the C<sub>T</sub> value for each of the four targets examined. Inoculation with 1 particle cell gave no detectable increase in transcript abundance but an increase was observed using 10 particles per cell and the dose response curves strongly suggest that lower doses have an effect. Interpreting these data in the context of infection is not straightforward as particle&#x02236;infectivity ratios for herpes simplex virus are, at best, 20 or more. On this basis a single infectious unit per cell is clearly sufficient to increase transcript abundance, indicating that signalling occurs at &#x02018;physiological&#x02019; multiplicities of infection.</p></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p id="__p52" class="p p-first">Evidence from previous studies using soluble HSV-1 glycoprotein and UV-inactivated virus suggested that binding of HSV-1 virions to the cell surface might be sufficient to stimulate intracellular signalling pathways. We undertook preliminary microarray studies with entry-defective HSV-1 virions and identified a number of pathways that were stimulated at early time points during infection.</p><p id="__p53">Microarray experiments are inevitably vulnerable to false positives and negatives due to non-specific binding of labelled cDNA probes, necessitating a more robust follow-up with highly sensitive methods. Due to such confounders, these data were used exclusively as a guide to select, for real-time PCR, the transcriptional targets of intracellular signalling pathways stimulated after inoculation with entry-defective HSV-1.</p><p id="__p54">Gene targets associated with the NF-&#x003ba;B, JAK/STAT/Src, and PI3K/Akt pathways were shown to be differentially expressed after inoculation with glycoprotein-deficient virions, with the majority of signalling events being associated with the presence of gD on the envelope. Nineteen other signalling pathways present on the preliminary microarray experiments, and confirmed by real-time PCR, were not stimulated (data not shown). These results are compatible with our model, shown in <a href="/pmc/articles/PMC2832691/figure/pone-0009560-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0009560-g003" rid-ob="ob-pone-0009560-g003" co-legend-rid="lgnd_pone-0009560-g003"><span>Fig. 3</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0009560-g003" co-legend-rid="lgnd_pone-0009560-g003"><a href="/pmc/articles/PMC2832691/figure/pone-0009560-g003/" target="figure" rid-figpopup="pone-0009560-g003" rid-ob="ob-pone-0009560-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140037172269728" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2832691_pone.0009560.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0009560.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2832691/bin/pone.0009560.g003.jpg" /></a></div><div id="largeobj_idm140037172269728" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2832691/figure/pone-0009560-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0009560-g003"><div><a class="figpopup" href="/pmc/articles/PMC2832691/figure/pone-0009560-g003/" target="figure" rid-figpopup="pone-0009560-g003" rid-ob="ob-pone-0009560-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Model for glycoprotein-receptor interactions in the induction of intracellular signalling pathways by HSV-1.</strong><p id="__p55">Glycoprotein D acts as the main signalling molecule on the surface of the HSV-1 envelope. gH interacts with &#x003b1;<sub>v</sub>&#x003b2;<sub>3</sub> integrins to potentially trigger the production of IFN-&#x003b2;, which is known to involve IRF-3 and 7 <a href="#pone.0009560-Honda1" rid="pone.0009560-Honda1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235207">[48]</a>. Binding by gD to HvEM may lead to the activation of TRAF molecules, which in turn stimulate the NF-&#x003ba;B signaling cascade. This pathway up-regulates a number of cellular genes in addition to augmenting early viral gene expression. NF-&#x003ba;B-responsive genes, <em>birc2 and birc3</em>, have an anti-apoptotic role, but paradoxically, inflammatory mediators such as <em>ccl2</em> are also up-regulated. gD-induced signalling of the Jak/Stat and Jak/Src pathways also results in the differential expression of genes associated with anti-apoptosis and inflammation. The up-regulation of c-Myc could lead to a corresponding increase in <em>cdk2</em>, which has a role in promoting DNA replication and gene transcription during infection. It should be noted that most signalling cascades have been elucidated in non-fibroblast cells lines, so the role of specific kinases may vary in HFFs.</p></div></div></div><p id="__p56">Real-time PCR confirmed that changes in transcription associated with the NF-&#x003ba;B, JAK/STAT, JAK/Src and PI3K pathways were modulated as a result of virion binding, all of which required gD on the envelope surface To demonstrate that signalling occurred at physiologically relevant multiplicities of infection, HFFs were inoculated with either 1000, 100, 10 or 1 particles per cell of entry-defective HSV-1. Changes in gene transcription occurred in a dose-dependent manner and were detectable at 10 virus particles per cell. Given the particle&#x02236;infectivity ratios usually quoted for HSV1, we argue that this corresponds to physiological conditions (i.e. less than one infectious unit per cell), but it is impossible to know the circumstances that pertain <em>in vivo</em> when a single cell becomes infected. What seems almost certain is that an infected cell will normally present an uninfected neighbouring cell with 10 or more progeny particles.</p><p id="__p57">HSV-1, as well as beta- and gammaherpesviruses, are capable of stimulating the NF-&#x003ba;B pathway in a bi-phasic manner, with our data supporting that an early, transient induction is reliant on virions expressing gD <a href="#pone.0009560-Amici1" rid="pone.0009560-Amici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235188">[8]</a>\n<a href="#pone.0009560-Johnson1" rid="pone.0009560-Johnson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235166">[32]</a>&#x02013;<a href="#pone.0009560-DAddario3" rid="pone.0009560-DAddario3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235179">[33]</a>. Suppression of NF-&#x003ba;B activity is via negative feedback up-regulation of the inhibitor I&#x003ba;B&#x003b1; (<em>nfkbia</em>), which was also stimulated by the binding of entry-defective HSV-1 virions. The triggering of early NF-&#x003ba;B transcriptional activity was most likely through the coupling of gD on entry-defective virions to the TNF superfamily receptor HvEM <a href="#pone.0009560-Sciortino1" rid="pone.0009560-Sciortino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235200">[1]</a>. In doing so, not only does the initial activation of this pathway allow for the subsequent sequestration of the NF-&#x003ba;B p65 subunit to the ICP0 promoter, but is crucial for immediate-early gene transcription and subsequent HSV-1 replication <a href="#pone.0009560-Amici1" rid="pone.0009560-Amici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235171">[8]</a>.</p><p id="__p58">Intracellular signalling induced by soluble gD can protect against Fas-mediated apoptosis with inhibition of NF-&#x003ba;B signalling leading to a loss of this protection <a href="#pone.0009560-Medici1" rid="pone.0009560-Medici1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235210">[6]</a>. Infection with UV-inactivated virions also led to an increase in the expression of the anti-apoptotic protein c-IAP2 (<em>birc3</em>), which we have demonstrated to be up-regulated after inoculation with entry-defective virions containing gD. Additional studies have supported the anti-apoptotic role for NF-&#x003ba;B during HSV-1 infection yet there are conflicting data that demonstrate possible pro-apoptotic activity <a href="#pone.0009560-Gregory1" rid="pone.0009560-Gregory1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235186">[34]</a>\n<a href="#pone.0009560-Gregory1" rid="pone.0009560-Gregory1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235221">[35]</a>. This inconsistency may be due to differing cell types used in those studies. Primary human foreskin fibroblasts have been shown to be resistant to apoptosis after infection with recombinant HSV-1 that is unable to express ICP4 or ICP27 whereas infection with either virus has been shown to cause apoptosis in transformed cell lines <a href="#pone.0009560-Aubert1" rid="pone.0009560-Aubert1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235211">[36]</a>.</p><p id="__p59">Aspects of the HSV-1 life cycle, such as stimulating the progression of the cell cycle in the absence of serum, may be sufficient to induce a stress response and trigger apoptosis. Both <em>bcl2</em> (Bcl-2) and <em>bcl2l1</em> (Bcl-xl) belong to the Bcl-2 family of apoptosis regulators that provide cellular protection from a range of harmful stimuli such as cytokine deprivation, UV- and &#x003b3;-irradiation <a href="#pone.0009560-Huang1" rid="pone.0009560-Huang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235197">[37]</a>. Bcl-2 and Bcl-xl are found in the outer mitochondrial membrane and are thought to suppress apoptosis by blocking mitochondrial outer-membrane permeabilisation through the sequestration of pro-apoptotic Bcl2 family members <a href="#pone.0009560-Cory1" rid="pone.0009560-Cory1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235216">[38]</a>. Given the up-regulation of four anti-apoptotic genes, <em>birc2</em>, <em>birc3</em>, <em>bcl2</em> and <em>bcl2l1</em>, through the activation of multiple signalling pathways by entry-defective HSV-1, this establishes a role for gD binding in shifting the intracellular environment towards a more anti- apoptotic stance.</p><p id="__p60">It is less apparent as to the biological relevance of an innate immune response stimulated through HSV-1 binding. It may be that there is a &#x0201c;cost&#x0201d; associated with altering the intracellular environment, which leads to the differential expression of cytokines, such as <em>ccl2</em>, that are under similar transcriptional regulation as those host factors that are favourable for virus replication.</p><p id="__p61">Signalling by secreted Type I IFNs occurs through the Jak/Stat pathway results in the expression of various ISGs; a response that is also triggered by virus entry <a href="#pone.0009560-Collins1" rid="pone.0009560-Collins1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235180">[39]</a>. Nevertheless, productive infection with HSV-1 can down-regulate the triggered ISG response, allowing viral replication to continue unhindered <a href="#pone.0009560-Noyce1" rid="pone.0009560-Noyce1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235191">[40]</a>. Despite our evidence that gD binding by entry-defective virions can induce IFN-&#x003b1; mRNA expression, independent of gD glycosylation status, these data also fit with published observations that binding by HSV-1 is insufficient to cause the up-regulation of interferon-stimulated genes <a href="#pone.0009560-Preston1" rid="pone.0009560-Preston1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235168">[30]</a>. The up-regulation of IFN-&#x003b2;, albeit it through a different mechanism, is suggestive of a previously unidentified role for gH in eliciting a change in host gene expression. An entry-defective HSV-1 mutant lacking gB that also contains an RGE rather than the integrin binding RGD motif of gH has been constructed and future studies may further elicit the role of gH in interferon stimulation.</p><p id="__p62">The methodology used here required the serum-starvation of primary human fibroblasts for five days. In the absence of serum, primary fibroblasts rapidly enter a quiescent state. As a DNA virus that requires host nuclear factors to replicate its genome, it is therefore not surprising that HSV-1 would stimulate cells from a G0 state into one that would favour DNA replication and possibly promote the transcription of viral genes.</p><p id="__p63">Quiescent cells <em>in vitro</em> have very low levels expression of the transcription factor c-Myc. Its up-regulation is rapidly induced after mitogenic stimulation or the introduction of serum and increased expression of c-Myc is consistent with the advancement of cellular proliferation <a href="#pone.0009560-Dang1" rid="pone.0009560-Dang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235193">[41]</a>. Control of <em>myc</em> transcription can be influenced by a number of pathways, including PI3K/Akt signalling, which was shown here to occur as a result of binding by gD. A central role for c-Myc in promoting cell-cycle progression is evident from the genes that it can up-regulate such as eIF2 <a href="#pone.0009560-Rosenwald1" rid="pone.0009560-Rosenwald1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235194">[42]</a>. Progression of the cell cycle depends on the additional activity of cyclin-dependent kinases. By interacting with the promoters for genes encoding cyclins and cyclin-dependent kinases, c-Myc can influence the advancement on the cell cycle into the G1/S phase <a href="#pone.0009560-Coller1" rid="pone.0009560-Coller1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235160">[43]</a>.</p><p id="__p64">Cyclin-dependent kinase 2 (CDK2) is one such downstream target of c-Myc activity, as well as the Androgen pathway, highlighting the signalling cross-talk that may occur <a href="#pone.0009560-Beier1" rid="pone.0009560-Beier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235201">[44]</a>. CDK2 is involved in the progression of the cell cycle from G1 through to S phase. Transient activation of CDK2 was shown to occur early in HSV-2 infection at two hours post-infection, and is crucial in early HSV-1 infection <a href="#pone.0009560-Hossain1" rid="pone.0009560-Hossain1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235172">[45]</a>\n<a href="#pone.0009560-Schang1" rid="pone.0009560-Schang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235198">[46]</a>. Kinase action by the cyclin A/CDK2 complex liberates the bound transcription factor E2F from Rb, a transcription factor that has previously been shown to be active during HSV-1 infection <a href="#pone.0009560-Advani1" rid="pone.0009560-Advani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_672235196">[47]</a>.</p><p id="__p65" class="p p-last">Epithelial cells at the initial site of HSV-1 infection <em>in vivo</em> are likely to be in a resting state, necessitating the virus to evolve a pre-entry signalling mechanism by which to stimulate the cell to provide host factors that are necessary for viral replication. We have demonstrated that signalling induced by HSV-1 glycoproteins, primarily gD, has the potential to: activate cellular transcription factors that augment viral gene transcription, differentially express a number of cellular genes so as to condition the cell for optimal replication or, alternatively, signal transduction may occur as a secondary effect to the appropriation of cellular receptors to achieve viral entry.</p></div><div id="s5" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="s5title">Supporting Information</h2><!--/article/body/sec/--><div class="sec suppmat" id="pone.0009560.s001"><h4>Table S1</h4><p id="__p66">Normalised datasets for genes differentially expressed on a signalling-specific microarray after infection with entry-defective HSV-1.</p><p id="__p67">(0.14 MB XLS)</p><div class="sup-box half_rhythm" id="idm140037133138832"><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s001.xls" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(133K, xls)</sup></div></div><div class="sec suppmat" id="pone.0009560.s002"><h4>Table S2</h4><p id="__p69">Primers used in real-time PCR to determine the relative abundance of corresponding mRNA transcripts.</p><p id="__p70">(0.28 MB DOC)</p><div class="sup-box half_rhythm" id="idm140037133134272"><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s002.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(274K, doc)</sup></div></div><div class="sec suppmat" id="pone.0009560.s003"><h4>Figure S1</h4><p id="__p72">Characteristics of virions treated with PNGase.</p><p id="__p73">(0.76 MB PDF)</p><div class="sup-box half_rhythm" id="idm140037120301328"><a href="/pmc/articles/PMC2832691/bin/pone.0009560.s003.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(738K, pdf)</sup></div></div></div><div id="idm140037173264608" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140037173264608title">Acknowledgments</h2><div class="sec"><p id="__p75">We thank Susanne Bell for invaluable technical assistance and Helena Browne for helpful discussions and critical reading of the manuscript.</p></div></div><div id="idm140037173263760" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140037173263760title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140037173263632"><p id="__p76" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm140037173262416"><p id="__p77" class="p p-first-last"><strong>Funding: </strong>This work was supported by Wellcome Trust grant WT073049MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm140037173260960" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140037173260960title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0009560-Sciortino1">1. <span class="element-citation">Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffr&#x000e8;-Cuculletto M, et al.  Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD. <span><span class="ref-journal">Biochem Pharmacol. </span>2008;<span class="ref-vol">76</span>:1522\xe2\x80\x9332.</span> [<a href="/pubmed/18723002" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=Involvement+of+gD/HVEM+interaction+in+NF-kB-dependent+inhibition+of+apoptosis+by+HSV-1+gD.&amp;author=MT+Sciortino&amp;author=MA+Medici&amp;author=F+Marino-Merlo&amp;author=D+Zaccaria&amp;author=M+Giuffr&#x000e8;-Cuculletto&amp;volume=76&amp;publication_year=2008&amp;pages=1522-32&amp;pmid=18723002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Heldwein1">2. <span class="element-citation">Heldwein EE, Krummenacher C. Entry of herpesviruses into mammalian cells. <span><span class="ref-journal">Cell Mol Life Sci. </span>2008;<span class="ref-vol">65</span>:1653\xe2\x80\x931668.</span> [<a href="/pubmed/18351291" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Life+Sci&amp;title=Entry+of+herpesviruses+into+mammalian+cells.&amp;author=EE+Heldwein&amp;author=C+Krummenacher&amp;volume=65&amp;publication_year=2008&amp;pages=1653-1668&amp;pmid=18351291&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Browne1">3. <span class="element-citation">Browne H. The role of glycoprotein H in herpesvirus membrane fusion. <span><span class="ref-journal">Protein Pept Lett. </span>2009;<span class="ref-vol">16</span>:760\xe2\x80\x93765.</span> [<a href="/pubmed/19601905" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Pept+Lett&amp;title=The+role+of+glycoprotein+H+in+herpesvirus+membrane+fusion.&amp;author=H+Browne&amp;volume=16&amp;publication_year=2009&amp;pages=760-765&amp;pmid=19601905&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Parry1">4. <span class="element-citation">Parry C, Bell S, Minson T, Browne H. Herpes simplex virus type 1 glycoprotein H binds to alphavbeta3 integrins. <span><span class="ref-journal">J Gen Virol. </span>2005;<span class="ref-vol">86</span>:7\xe2\x80\x9310.</span> [<a href="/pubmed/15604426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Herpes+simplex+virus+type+1+glycoprotein+H+binds+to+alphavbeta3+integrins.&amp;author=C+Parry&amp;author=S+Bell&amp;author=T+Minson&amp;author=H+Browne&amp;volume=86&amp;publication_year=2005&amp;pages=7-10&amp;pmid=15604426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Satoh1">5. <span class="element-citation">Satoh T, Arii J, Suenaga T, Wang J, Kogure A, et al.  PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. <span><span class="ref-journal">Cell. </span>2008;<span class="ref-vol">132</span>:935\xe2\x80\x93944.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2394663/">PMC free article</a>]</span> [<a href="/pubmed/18358807" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=PILRalpha+is+a+herpes+simplex+virus-1+entry+coreceptor+that+associates+with+glycoprotein+B.&amp;author=T+Satoh&amp;author=J+Arii&amp;author=T+Suenaga&amp;author=J+Wang&amp;author=A+Kogure&amp;volume=132&amp;publication_year=2008&amp;pages=935-944&amp;pmid=18358807&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Medici1">6. <span class="element-citation">Medici MA, Sciortino MT, Perri D, Amici C, Avitabile E, et al.  Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis: ROLE OF NUCLEAR FACTOR {kappa}B. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:36059\xe2\x80\x9336067.</span> [<a href="/pubmed/12844494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Protection+by+Herpes+Simplex+Virus+Glycoprotein+D+against+Fas-mediated+Apoptosis:+ROLE+OF+NUCLEAR+FACTOR+{kappa}B.&amp;author=MA+Medici&amp;author=MT+Sciortino&amp;author=D+Perri&amp;author=C+Amici&amp;author=E+Avitabile&amp;volume=278&amp;publication_year=2003&amp;pages=36059-36067&amp;pmid=12844494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Patel1">7. <span class="element-citation">Patel A, Hanson J, McLean TI, Olgiate J, Hilton M, et al.  Herpes Simplex Virus Type 1 Induction of Persistent NF-&#x003ba;B Nuclear Translocation Increases the Efficiency of Virus Replication&#x0002a;1. <span><span class="ref-journal">Virology. </span>1998;<span class="ref-vol">247</span>:212\xe2\x80\x93222.</span> [<a href="/pubmed/9705914" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Herpes+Simplex+Virus+Type+1+Induction+of+Persistent+NF-&#x003ba;B+Nuclear+Translocation+Increases+the+Efficiency+of+Virus+Replication&#x0002a;1.&amp;author=A+Patel&amp;author=J+Hanson&amp;author=TI+McLean&amp;author=J+Olgiate&amp;author=M+Hilton&amp;volume=247&amp;publication_year=1998&amp;pages=212-222&amp;pmid=9705914&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Amici1">8. <span class="element-citation">Amici C, Rossi A, Costanzo A, Ciafre S, Marinari B, et al.  Herpes Simplex Virus Disrupts NF-{kappa}B Regulation by Blocking Its Recruitment on the I{kappa}B{alpha} Promoter and Directing the Factor on Viral Genes. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:7110\xe2\x80\x937117.</span> [<a href="/pubmed/16407234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Herpes+Simplex+Virus+Disrupts+NF-{kappa}B+Regulation+by+Blocking+Its+Recruitment+on+the+I{kappa}B{alpha}+Promoter+and+Directing+the+Factor+on+Viral+Genes.&amp;author=C+Amici&amp;author=A+Rossi&amp;author=A+Costanzo&amp;author=S+Ciafre&amp;author=B+Marinari&amp;volume=281&amp;publication_year=2006&amp;pages=7110-7117&amp;pmid=16407234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Sciortino2">9. <span class="element-citation">Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffr&#x000e8; M, et al.  Signaling Pathway Used by HSV-1 to Induce NF-kB Activation. <span><span class="ref-journal">Annals of the New York Academy of Sciences. </span>2007;<span class="ref-vol">1096</span>:89\xe2\x80\x9396.</span> [<a href="/pubmed/17405920" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Signaling+Pathway+Used+by+HSV-1+to+Induce+NF-kB+Activation.&amp;author=MT+Sciortino&amp;author=MA+Medici&amp;author=F+Marino-Merlo&amp;author=D+Zaccaria&amp;author=M+Giuffr&#x000e8;&amp;volume=1096&amp;publication_year=2007&amp;pages=89-96&amp;pmid=17405920&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Simmen1">10. <span class="element-citation">Simmen KA, Singh J, Luukkonen BGM, Lopper M, Bittner A, et al.  Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:7140\xe2\x80\x937145.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC34636/">PMC free article</a>]</span> [<a href="/pubmed/11390970" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Global+modulation+of+cellular+transcription+by+human+cytomegalovirus+is+initiated+by+viral+glycoprotein+B.&amp;author=KA+Simmen&amp;author=J+Singh&amp;author=BGM+Luukkonen&amp;author=M+Lopper&amp;author=A+Bittner&amp;volume=98&amp;publication_year=2001&amp;pages=7140-7145&amp;pmid=11390970&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-DAddario1">11. <span class="element-citation">D\'Addario M, Ahmad A, Morgan A, Menezes J. Binding of the epstein-barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-&#x003b1; gene expression in monocytic cells via NF-&#x003ba;b involving PKC, PI3-K and tyrosine kinases1. <span><span class="ref-journal">Journal of molecular biology. </span>2000;<span class="ref-vol">298</span>:765\xe2\x80\x93778.</span> [<a href="/pubmed/10801347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+molecular+biology&amp;title=Binding+of+the+epstein-barr+virus+major+envelope+glycoprotein+gp350+results+in+the+upregulation+of+the+TNF-&#x003b1;+gene+expression+in+monocytic+cells+via+NF-&#x003ba;b+involving+PKC,+PI3-K+and+tyrosine+kinases1.&amp;author=M+D\'Addario&amp;author=A+Ahmad&amp;author=A+Morgan&amp;author=J+Menezes&amp;volume=298&amp;publication_year=2000&amp;pages=765-778&amp;pmid=10801347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-DAddario2">12. <span class="element-citation">D\'Addario M, Libermann TA, Xu J, Ahmad A, Menezes J. Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-&#x003ba;B and different signaling pathways1. <span><span class="ref-journal">Journal of molecular biology. </span>2001;<span class="ref-vol">308</span>:501\xe2\x80\x93514.</span> [<a href="/pubmed/11327783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+molecular+biology&amp;title=Epstein-Barr+virus+and+its+glycoprotein-350+upregulate+IL-6+in+human+B-lymphocytes+via+CD21,+involving+activation+of+NF-&#x003ba;B+and+different+signaling+pathways1.&amp;author=M+D\'Addario&amp;author=TA+Libermann&amp;author=J+Xu&amp;author=A+Ahmad&amp;author=J+Menezes&amp;volume=308&amp;publication_year=2001&amp;pages=501-514&amp;pmid=11327783&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Cai1">13. <span class="element-citation">Cai WH, Gu B, Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. <span><span class="ref-journal">J Virol. </span>1988;<span class="ref-vol">62</span>:2596\xe2\x80\x93604.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC253689/">PMC free article</a>]</span> [<a href="/pubmed/2839688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Role+of+glycoprotein+B+of+herpes+simplex+virus+type+1+in+viral+entry+and+cell+fusion.&amp;author=WH+Cai&amp;author=B+Gu&amp;author=S+Person&amp;volume=62&amp;publication_year=1988&amp;pages=2596-604&amp;pmid=2839688&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Forrester1">14. <span class="element-citation">Forrester A, Farrell H, Wilkinson G, Kaye J, Davis-Poynter N, et al.  Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. <span><span class="ref-journal">J Virol. </span>1992;<span class="ref-vol">66</span>:341\xe2\x80\x93348.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC238293/">PMC free article</a>]</span> [<a href="/pubmed/1309250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Construction+and+properties+of+a+mutant+of+herpes+simplex+virus+type+1+with+glycoprotein+H+coding+sequences+deleted.&amp;author=A+Forrester&amp;author=H+Farrell&amp;author=G+Wilkinson&amp;author=J+Kaye&amp;author=N+Davis-Poynter&amp;volume=66&amp;publication_year=1992&amp;pages=341-348&amp;pmid=1309250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Ligas1">15. <span class="element-citation">Ligas MW, Johnson DC. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. <span><span class="ref-journal">J Virol. </span>1988;<span class="ref-vol">62</span>:1486\xe2\x80\x9394.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC253172/">PMC free article</a>]</span> [<a href="/pubmed/2833603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=A+herpes+simplex+virus+mutant+in+which+glycoprotein+D+sequences+are+replaced+by+beta-galactosidase+sequences+binds+to+but+is+unable+to+penetrate+into+cells.&amp;author=MW+Ligas&amp;author=DC+Johnson&amp;volume=62&amp;publication_year=1988&amp;pages=1486-94&amp;pmid=2833603&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Roop1">16. <span class="element-citation">Roop C, Hutchinson L, Johnson DC. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. <span><span class="ref-journal">J Virol. </span>1993;<span class="ref-vol">67</span>:2285\xe2\x80\x9397.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC240370/">PMC free article</a>]</span> [<a href="/pubmed/8383241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=A+mutant+herpes+simplex+virus+type+1+unable+to+express+glycoprotein+L+cannot+enter+cells,+and+its+particles+lack+glycoprotein+H.&amp;author=C+Roop&amp;author=L+Hutchinson&amp;author=DC+Johnson&amp;volume=67&amp;publication_year=1993&amp;pages=2285-97&amp;pmid=8383241&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-NaldinhoSouto1">17. <span class="element-citation">Naldinho-Souto R, Browne H, Minson T. Herpes Simplex Virus Tegument Protein VP16 Is a Component of Primary Enveloped Virions. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:2582\xe2\x80\x932584.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1395364/">PMC free article</a>]</span> [<a href="/pubmed/16474165" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Herpes+Simplex+Virus+Tegument+Protein+VP16+Is+a+Component+of+Primary+Enveloped+Virions.&amp;author=R+Naldinho-Souto&amp;author=H+Browne&amp;author=T+Minson&amp;volume=80&amp;publication_year=2006&amp;pages=2582-2584&amp;pmid=16474165&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Babic1">18. <span class="element-citation">Babic N, Rodger G, Arthur J, Minson AC. A study of primary neuronal infection by mutants of herpes simplex virus type 1 lacking dispensable and non-dispensable glycoproteins. <span><span class="ref-journal">J Gen Virol. </span>1999;<span class="ref-vol">80</span>:2403\xe2\x80\x932409.</span> [<a href="/pubmed/10501494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=A+study+of+primary+neuronal+infection+by+mutants+of+herpes+simplex+virus+type+1+lacking+dispensable+and+non-dispensable+glycoproteins.&amp;author=N+Babic&amp;author=G+Rodger&amp;author=J+Arthur&amp;author=AC+Minson&amp;volume=80&amp;publication_year=1999&amp;pages=2403-2409&amp;pmid=10501494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Boursnell1">19. <span class="element-citation">Boursnell ME, Entwisle C, Blakeley D, Roberts C, Duncan IA, et al.  A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. <span><span class="ref-journal">J Infect Dis. </span>1997;<span class="ref-vol">175</span>:16\xe2\x80\x9325.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109964/">PMC free article</a>]</span> [<a href="/pubmed/8985191" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=A+genetically+inactivated+herpes+simplex+virus+type+2+(HSV-2)+vaccine+provides+effective+protection+against+primary+and+recurrent+HSV-2+disease.&amp;author=ME+Boursnell&amp;author=C+Entwisle&amp;author=D+Blakeley&amp;author=C+Roberts&amp;author=IA+Duncan&amp;volume=175&amp;publication_year=1997&amp;pages=16-25&amp;pmid=8985191&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Rodger1">20. <span class="element-citation">Rodger G, Boname J, Bell S, Minson T. Assembly and Organization of Glycoproteins B, C, D, and H in Herpes Simplex Virus Type 1 Particles Lacking Individual Glycoproteins: No Evidence for the Formation of a Complex of These Molecules. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:710\xe2\x80\x93716.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC113967/">PMC free article</a>]</span> [<a href="/pubmed/11134284" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Assembly+and+Organization+of+Glycoproteins+B,+C,+D,+and+H+in+Herpes+Simplex+Virus+Type+1+Particles+Lacking+Individual+Glycoproteins:+No+Evidence+for+the+Formation+of+a+Complex+of+These+Molecules.&amp;author=G+Rodger&amp;author=J+Boname&amp;author=S+Bell&amp;author=T+Minson&amp;volume=75&amp;publication_year=2001&amp;pages=710-716&amp;pmid=11134284&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Watson1">21. <span class="element-citation">Watson DH, Russell WC, Wildy P. Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique. <span><span class="ref-journal">Virology. </span>1963;<span class="ref-vol">19</span>:250\xe2\x80\x9360.</span> [<a href="/pubmed/13999204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Electron+microscopic+particle+counts+on+herpes+virus+using+the+phosphotungstate+negative+staining+technique.&amp;author=DH+Watson&amp;author=WC+Russell&amp;author=P+Wildy&amp;volume=19&amp;publication_year=1963&amp;pages=250-60&amp;pmid=13999204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Paludan1">22. <span class="element-citation">Paludan SR, Mogensen SC. Virus-Cell Interactions Regulating Induction of Tumor Necrosis Factor Alpha Production in Macrophages Infected with Herpes Simplex Virus. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:10170\xe2\x80\x9310178.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114591/">PMC free article</a>]</span> [<a href="/pubmed/11581385" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Virus-Cell+Interactions+Regulating+Induction+of+Tumor+Necrosis+Factor+Alpha+Production+in+Macrophages+Infected+with+Herpes+Simplex+Virus.&amp;author=SR+Paludan&amp;author=SC+Mogensen&amp;volume=75&amp;publication_year=2001&amp;pages=10170-10178&amp;pmid=11581385&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Rozen1">23. <span class="element-citation">Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. <span><span class="ref-journal">Methods Mol Biol. </span>2000;<span class="ref-vol">132</span>:365\xe2\x80\x9386.</span> [<a href="/pubmed/10547847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Mol+Biol&amp;title=Primer3+on+the+WWW+for+general+users+and+for+biologist+programmers.&amp;author=S+Rozen&amp;author=H+Skaletsky&amp;volume=132&amp;publication_year=2000&amp;pages=365-86&amp;pmid=10547847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Pfaffl1">24. <span class="element-citation">Pfaffl MW. A new mathematical model for relative quantification in real-time RT&#x02013;PCR. <span><span class="ref-journal">Nucleic Acids Res. </span>2001;<span class="ref-vol">29</span>:e45.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC55695/">PMC free article</a>]</span> [<a href="/pubmed/11328886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=A+new+mathematical+model+for+relative+quantification+in+real-time+RT&#x02013;PCR.&amp;author=MW+Pfaffl&amp;volume=29&amp;publication_year=2001&amp;pages=e45&amp;pmid=11328886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Minson1">25. <span class="element-citation">Minson AC, Hodgman TC, Digard P, Hancock DC, Bell SE, et al.  An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. <span><span class="ref-journal">J Gen Virol. </span>1986;<span class="ref-vol">67 (Pt 6)</span>:1001\xe2\x80\x931013.</span> [<a href="/pubmed/2423636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=An+analysis+of+the+biological+properties+of+monoclonal+antibodies+against+glycoprotein+D+of+herpes+simplex+virus+and+identification+of+amino+acid+substitutions+that+confer+resistance+to+neutralization.&amp;author=AC+Minson&amp;author=TC+Hodgman&amp;author=P+Digard&amp;author=DC+Hancock&amp;author=SE+Bell&amp;volume=67+(Pt+6)&amp;publication_year=1986&amp;pages=1001-1013&amp;pmid=2423636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-McLean1">26. <span class="element-citation">McLean C, Buckmaster A, Hancock D, Buchan A, Fuller A, et al.  Monoclonal antibodies to three non-glycosylated antigens of herpes simplex virus type 2. <span><span class="ref-journal">J Gen Virol. </span>1982;<span class="ref-vol">63</span>:297\xe2\x80\x93305.</span> [<a href="/pubmed/6296279" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Monoclonal+antibodies+to+three+non-glycosylated+antigens+of+herpes+simplex+virus+type+2.&amp;author=C+McLean&amp;author=A+Buckmaster&amp;author=D+Hancock&amp;author=A+Buchan&amp;author=A+Fuller&amp;volume=63&amp;publication_year=1982&amp;pages=297-305&amp;pmid=6296279&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Browne2">27. <span class="element-citation">Browne H, Bell S, Minson T, Wilson DW. An endoplasmic reticulum-retained herpes simplex virus glycoprotein H is absent from secreted virions: evidence for reenvelopment during egress. <span><span class="ref-journal">J Virol. </span>1996;<span class="ref-vol">70</span>:4311\xe2\x80\x934316.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC190363/">PMC free article</a>]</span> [<a href="/pubmed/8676453" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=An+endoplasmic+reticulum-retained+herpes+simplex+virus+glycoprotein+H+is+absent+from+secreted+virions:+evidence+for+reenvelopment+during+egress.&amp;author=H+Browne&amp;author=S+Bell&amp;author=T+Minson&amp;author=DW+Wilson&amp;volume=70&amp;publication_year=1996&amp;pages=4311-4316&amp;pmid=8676453&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Thompson1">28. <span class="element-citation">Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. <span><span class="ref-journal">Gene. </span>1991;<span class="ref-vol">103</span>:171\xe2\x80\x93177.</span> [<a href="/pubmed/1889744" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Modulation+of+firefly+luciferase+stability+and+impact+on+studies+of+gene+regulation.&amp;author=JF+Thompson&amp;author=LS+Hayes&amp;author=DB+Lloyd&amp;volume=103&amp;publication_year=1991&amp;pages=171-177&amp;pmid=1889744&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Ankel1">29. <span class="element-citation">Ankel H, Westra DF, Welling-Wester S, Lebon P. Induction of Interferon-&#x003b1; by Glycoprotein D of Herpes Simplex Virus: A Possible Role of Chemokine Receptors. <span><span class="ref-journal">Virology. </span>1998;<span class="ref-vol">251</span>:317\xe2\x80\x93326.</span> [<a href="/pubmed/9837796" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Induction+of+Interferon-&#x003b1;+by+Glycoprotein+D+of+Herpes+Simplex+Virus:+A+Possible+Role+of+Chemokine+Receptors.&amp;author=H+Ankel&amp;author=DF+Westra&amp;author=S+Welling-Wester&amp;author=P+Lebon&amp;volume=251&amp;publication_year=1998&amp;pages=317-326&amp;pmid=9837796&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Preston1">30. <span class="element-citation">Preston CM, Harman AN, Nicholl MJ. Activation of Interferon Response Factor-3 in Human Cells Infected with Herpes Simplex Virus Type 1 or Human Cytomegalovirus. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:8909\xe2\x80\x938916.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114459/">PMC free article</a>]</span> [<a href="/pubmed/11533154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Activation+of+Interferon+Response+Factor-3+in+Human+Cells+Infected+with+Herpes+Simplex+Virus+Type+1+or+Human+Cytomegalovirus.&amp;author=CM+Preston&amp;author=AN+Harman&amp;author=MJ+Nicholl&amp;volume=75&amp;publication_year=2001&amp;pages=8909-8916&amp;pmid=11533154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Laude1">31. <span class="element-citation">Laude H, Gelfi J, Lavenant L, Charley B. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. <span><span class="ref-journal">J Virol. </span>1992;<span class="ref-vol">66</span>:743\xe2\x80\x93749.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC240773/">PMC free article</a>]</span> [<a href="/pubmed/1309909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Single+amino+acid+changes+in+the+viral+glycoprotein+M+affect+induction+of+alpha+interferon+by+the+coronavirus+transmissible+gastroenteritis+virus.&amp;author=H+Laude&amp;author=J+Gelfi&amp;author=L+Lavenant&amp;author=B+Charley&amp;volume=66&amp;publication_year=1992&amp;pages=743-749&amp;pmid=1309909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Johnson1">32. <span class="element-citation">Johnson RA, Wang X, Ma X, Huong S, Huang E. Human Cytomegalovirus Up-Regulates the Phosphatidylinositol 3-Kinase (PI3-K) Pathway: Inhibition of PI3-K Activity Inhibits Viral Replication and Virus-Induced Signaling. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:6022\xe2\x80\x936032.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114318/">PMC free article</a>]</span> [<a href="/pubmed/11390604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+Cytomegalovirus+Up-Regulates+the+Phosphatidylinositol+3-Kinase+(PI3-K)+Pathway:+Inhibition+of+PI3-K+Activity+Inhibits+Viral+Replication+and+Virus-Induced+Signaling.&amp;author=RA+Johnson&amp;author=X+Wang&amp;author=X+Ma&amp;author=S+Huong&amp;author=E+Huang&amp;volume=75&amp;publication_year=2001&amp;pages=6022-6032&amp;pmid=11390604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-DAddario3">33. <span class="element-citation">D\'Addario M, Ahmad A, Morgan A, Menezes J. Binding of the epstein-barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-[alpha] gene expression in monocytic cells via NF-[kappa]b involving PKC, PI3-K and tyrosine kinases. <span><span class="ref-journal">Journal of Molecular Biology. </span>2000;<span class="ref-vol">298</span>:765\xe2\x80\x93778.</span> [<a href="/pubmed/10801347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Molecular+Biology&amp;title=Binding+of+the+epstein-barr+virus+major+envelope+glycoprotein+gp350+results+in+the+upregulation+of+the+TNF-[alpha]+gene+expression+in+monocytic+cells+via+NF-[kappa]b+involving+PKC,+PI3-K+and+tyrosine+kinases.&amp;author=M+D\'Addario&amp;author=A+Ahmad&amp;author=A+Morgan&amp;author=J+Menezes&amp;volume=298&amp;publication_year=2000&amp;pages=765-778&amp;pmid=10801347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Gregory1">34. <span class="element-citation">Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:13582\xe2\x80\x9313590.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC533927/">PMC free article</a>]</span> [<a href="/pubmed/15564469" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Efficient+replication+by+herpes+simplex+virus+type+1+involves+activation+of+the+IkappaB+kinase-IkappaB-p65+pathway.&amp;author=D+Gregory&amp;author=D+Hargett&amp;author=D+Holmes&amp;author=E+Money&amp;author=SL+Bachenheimer&amp;volume=78&amp;publication_year=2004&amp;pages=13582-13590&amp;pmid=15564469&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Taddeo1">35. <span class="element-citation">Taddeo B, Esclatine A, Roizman B. The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2002;<span class="ref-vol">99</span>:17031\xe2\x80\x9317036.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC139264/">PMC free article</a>]</span> [<a href="/pubmed/12481033" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=The+patterns+of+accumulation+of+cellular+RNAs+in+cells+infected+with+a+wild-type+and+a+mutant+herpes+simplex+virus+1+lacking+the+virion+host+shutoff+gene.&amp;author=B+Taddeo&amp;author=A+Esclatine&amp;author=B+Roizman&amp;volume=99&amp;publication_year=2002&amp;pages=17031-17036&amp;pmid=12481033&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Aubert1">36. <span class="element-citation">Aubert M, Blaho JA. Viral oncoapoptosis of human tumor cells. <span><span class="ref-journal">Gene Ther. </span>2003;<span class="ref-vol">10</span>:1437\xe2\x80\x931445.</span> [<a href="/pubmed/12900758" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Viral+oncoapoptosis+of+human+tumor+cells.&amp;author=M+Aubert&amp;author=JA+Blaho&amp;volume=10&amp;publication_year=2003&amp;pages=1437-1445&amp;pmid=12900758&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Huang1">37. <span class="element-citation">Huang DC, Cory S, Strasser A. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. <span><span class="ref-journal">Oncogene. </span>1997;<span class="ref-vol">14</span>:405\xe2\x80\x9314.</span> [<a href="/pubmed/9053837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Bcl-2,+Bcl-XL+and+adenovirus+protein+E1B19kD+are+functionally+equivalent+in+their+ability+to+inhibit+cell+death.&amp;author=DC+Huang&amp;author=S+Cory&amp;author=A+Strasser&amp;volume=14&amp;publication_year=1997&amp;pages=405-14&amp;pmid=9053837&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Cory1">38. <span class="element-citation">Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. <span><span class="ref-journal">Nat Rev Cancer. </span>2002;<span class="ref-vol">2</span>:647\xe2\x80\x9356.</span> [<a href="/pubmed/12209154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=The+Bcl2+family:+regulators+of+the+cellular+life-or-death+switch.&amp;author=S+Cory&amp;author=JM+Adams&amp;volume=2&amp;publication_year=2002&amp;pages=647-56&amp;pmid=12209154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Collins1">39. <span class="element-citation">Collins SE, Noyce RS, Mossman KL. Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:1706\xe2\x80\x931717.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC369475/">PMC free article</a>]</span> [<a href="/pubmed/14747536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Innate+Cellular+Response+to+Virus+Particle+Entry+Requires+IRF3+but+Not+Virus+Replication.&amp;author=SE+Collins&amp;author=RS+Noyce&amp;author=KL+Mossman&amp;volume=78&amp;publication_year=2004&amp;pages=1706-1717&amp;pmid=14747536&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Noyce1">40. <span class="element-citation">Noyce RS, Collins SE, Mossman KL. Identification of a Novel Pathway Essential for the Immediate-Early, Interferon-Independent Antiviral Response to Enveloped Virions. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:226\xe2\x80\x93235.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1317555/">PMC free article</a>]</span> [<a href="/pubmed/16352547" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Identification+of+a+Novel+Pathway+Essential+for+the+Immediate-Early,+Interferon-Independent+Antiviral+Response+to+Enveloped+Virions.&amp;author=RS+Noyce&amp;author=SE+Collins&amp;author=KL+Mossman&amp;volume=80&amp;publication_year=2006&amp;pages=226-235&amp;pmid=16352547&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Dang1">41. <span class="element-citation">Dang CV. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. <span><span class="ref-journal">Mol Cell Biol. </span>1999;<span class="ref-vol">19</span>:1\xe2\x80\x9311.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC83860/">PMC free article</a>]</span> [<a href="/pubmed/9858526" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=c-Myc+Target+Genes+Involved+in+Cell+Growth,+Apoptosis,+and+Metabolism.&amp;author=CV+Dang&amp;volume=19&amp;publication_year=1999&amp;pages=1-11&amp;pmid=9858526&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Rosenwald1">42. <span class="element-citation">Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1993;<span class="ref-vol">90</span>:6175\xe2\x80\x936178.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC46890/">PMC free article</a>]</span> [<a href="/pubmed/8327497" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Increased+expression+of+eukaryotic+translation+initiation+factors+eIF-4E+and+eIF-2+alpha+in+response+to+growth+induction+by+c-myc.&amp;author=IB+Rosenwald&amp;author=DB+Rhoads&amp;author=LD+Callanan&amp;author=KJ+Isselbacher&amp;author=EV+Schmidt&amp;volume=90&amp;publication_year=1993&amp;pages=6175-6178&amp;pmid=8327497&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Coller1">43. <span class="element-citation">Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:3260\xe2\x80\x933265.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC16226/">PMC free article</a>]</span> [<a href="/pubmed/10737792" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Expression+analysis+with+oligonucleotide+microarrays+reveals+that+MYC+regulates+genes+involved+in+growth,+cell+cycle,+signaling,+and+adhesion.&amp;author=HA+Coller&amp;author=C+Grandori&amp;author=P+Tamayo&amp;author=T+Colbert&amp;author=ES+Lander&amp;volume=97&amp;publication_year=2000&amp;pages=3260-3265&amp;pmid=10737792&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Beier1">44. <span class="element-citation">Beier R, B&#x000fc;rgin A, Kiermaier A, Fero M, Karsunky H, et al.  Induction of cyclin E&#x02013;cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. <span><span class="ref-journal">EMBO J. </span>2000;<span class="ref-vol">19</span>:5813\xe2\x80\x935823.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC305784/">PMC free article</a>]</span> [<a href="/pubmed/11060032" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Induction+of+cyclin+E&#x02013;cdk2+kinase+activity,+E2F-dependent+transcription+and+cell+growth+by+Myc+are+genetically+separable+events.&amp;author=R+Beier&amp;author=A+B&#x000fc;rgin&amp;author=A+Kiermaier&amp;author=M+Fero&amp;author=H+Karsunky&amp;volume=19&amp;publication_year=2000&amp;pages=5813-5823&amp;pmid=11060032&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Hossain1">45. <span class="element-citation">Hossain A, Holt T, Ciacci-Zanella J, Jones C. Analysis of cyclin-dependent kinase activity after herpes simplex virus type 2 infection. <span><span class="ref-journal">J Gen Virol. </span>1997;<span class="ref-vol">78</span>:3341\xe2\x80\x933348.</span> [<a href="/pubmed/9400986" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Analysis+of+cyclin-dependent+kinase+activity+after+herpes+simplex+virus+type+2+infection.&amp;author=A+Hossain&amp;author=T+Holt&amp;author=J+Ciacci-Zanella&amp;author=C+Jones&amp;volume=78&amp;publication_year=1997&amp;pages=3341-3348&amp;pmid=9400986&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Schang1">46. <span class="element-citation">Schang LM, Phillips J, Schaffer PA. Requirement for Cellular Cyclin-Dependent Kinases in Herpes Simplex Virus Replication and Transcription. <span><span class="ref-journal">J Virol. </span>1998;<span class="ref-vol">72</span>:5626\xe2\x80\x935637.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC110224/">PMC free article</a>]</span> [<a href="/pubmed/9621021" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Requirement+for+Cellular+Cyclin-Dependent+Kinases+in+Herpes+Simplex+Virus+Replication+and+Transcription.&amp;author=LM+Schang&amp;author=J+Phillips&amp;author=PA+Schaffer&amp;volume=72&amp;publication_year=1998&amp;pages=5626-5637&amp;pmid=9621021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Advani1">47. <span class="element-citation">Advani SJ, Weichselbaum RR, Roizman B. E2F Proteins Are Posttranslationally Modified Concomitantly with a Reduction in Nuclear Binding Activity in Cells Infected with Herpes Simplex Virus 1. <span><span class="ref-journal">J Virol. </span>2000;<span class="ref-vol">74</span>:7842\xe2\x80\x937850.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC112314/">PMC free article</a>]</span> [<a href="/pubmed/10933691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=E2F+Proteins+Are+Posttranslationally+Modified+Concomitantly+with+a+Reduction+in+Nuclear+Binding+Activity+in+Cells+Infected+with+Herpes+Simplex+Virus+1.&amp;author=SJ+Advani&amp;author=RR+Weichselbaum&amp;author=B+Roizman&amp;volume=74&amp;publication_year=2000&amp;pages=7842-7850&amp;pmid=10933691&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0009560-Honda1">48. <span class="element-citation">Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. <span><span class="ref-journal">Nat Rev Immunol. </span>2006;<span class="ref-vol">6</span>:644\xe2\x80\x93658.</span> [<a href="/pubmed/16932750" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&amp;title=IRFs:+master+regulators+of+signalling+by+Toll-like+receptors+and+cytosolic+pattern-recognition+receptors.&amp;author=K+Honda&amp;author=T+Taniguchi&amp;volume=6&amp;publication_year=2006&amp;pages=644-658&amp;pmid=16932750&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2832691&amp;issue-id=185351&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2832691/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2832691/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2832691/pdf/pone.0009560.pdf">PDF (349K)</a></li> | <li><a href="#" data-citationid="PMC2832691" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2832691%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2832691%2F&amp;text=Binding%20of%20Herpes%20Simplex%20Virus%20Type-1%20Virions%20Leads%20to%20the%20Induction%20of%20Intracellular%20Signalling%20in%20the%20Absence%20of%20Virus%20Entry"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2832691%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20221426" data-aiid="2832691" data-aid="2832691" data-iid="185351" data-domainid="440" data-domain="plosone" data-accid="PMC2832691" data-md5="b4e2911c990f1390947cf6fab2170ae3"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:33:34-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B6431E9A371110000000007BF07BD&amp;ncbi_session=8A1B6431E9A4ADD1_1983SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2832691%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2832691/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B6431E9A4ADD1_1983SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'